The 2003-2008 World Outlook for Biotechnology 0597866147, 9780597866142
320 8 926KB
English Pages 227
Recommend Papers
![World Energy Outlook [2020]
9789264449237](https://ebin.pub/img/200x200/world-energy-outlook-2020-9789264449237-m-6135860.jpg)
![The 2000-2005 World Outlook for Nonmetallic Mineral Services [2000 ed.]
0757655106, 9780757655104](https://ebin.pub/img/200x200/the-2000-2005-world-outlook-for-nonmetallic-mineral-services-2000nbsped-0757655106-9780757655104.jpg)
![The 2000-2005 World Outlook for Pasta Sauces [2000 ed.]
0757653294, 9780757653292](https://ebin.pub/img/200x200/the-2000-2005-world-outlook-for-pasta-sauces-2000nbsped-0757653294-9780757653292.jpg)
![The 2000-2005 World Outlook for Electrical Measuring Devices [2000 ed.]
9780757656323, 0757656323](https://ebin.pub/img/200x200/the-2000-2005-world-outlook-for-electrical-measuring-devices-2000nbsped-9780757656323-0757656323.jpg)
![The 2000-2005 World Outlook for Pork [2000 ed.]
0757653391, 9780757653391](https://ebin.pub/img/200x200/the-2000-2005-world-outlook-for-pork-2000nbsped-0757653391-9780757653391.jpg)
![The 2000-2005 World Outlook for Video Game Consoles [2000 ed.]
0757654118, 9780757654114](https://ebin.pub/img/200x200/the-2000-2005-world-outlook-for-video-game-consoles-2000nbsped-0757654118-9780757654114.jpg)
File loading please wait...
Citation preview
The 2003-2008 World Outlook for Biotechnology
by Philip M. Parker, Ph.d. Eli Lilly Chaired Professor of Business, Innovation and Society INSEAD (Singapore, and Fontainebleau, France)
www.icongrouponline.com
Ó2003 ICON Group Ltd.
ii
COPYRIGHT NOTICE ISBN: 0-597-86614-7
All of ICON Group Ltd. publications are copyrighted. Copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs or other materials from our publications, please contact us to request permission. ICON Group Ltd. often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires, however, confirmed permission from ICON Group Ltd. Please read the full copyright notice, disclaimer, and user agreement provisions at the end of this report.
IMPORTANT DISCLAIMER
Neither ICON Group Ltd. nor its employees or the author of this report can be held accountable for the use and subsequent actions of the user of the information provided in this publication. Great efforts have been made to ensure the accuracy of the data, but we can not guarantee, given the volume of information, accuracy. Since the information given in this report is forward-looking, the reader should read the disclaimer statement and user agreement provisions at the end of this report.
www.icongrouponline.com
Ó2003 ICON Group Ltd.
iii
About the Author Dr. Philip M. Parker is the Eli Lilly Chaired Professor of Innovation, Business and Society at INSEAD where he has taught courses on global competitive strategy since 1988. He has also taught courses at MIT, Stanford University, Harvard University, UCLA, UCSD, and the Hong Kong University of Science and Technology. Professor Parker is the author of six books on the economic convergence of nations. These books introduce the notion of “physioeconomics” which foresees a lack of global convergence in economic behaviors due to physiological and physiographic forces. His latest book is "Physioeconomics: the basis for long-run economic growth" (MIT Press 2000). He has also published numerous articles in academic journals, including, the Rand Journal of Economics, Marketing Science, the Journal of International Business Studies, Technological Forecasting and Social Change, the International Journal of Forecasting, the European Management Journal, the European Journal of Operational Research, the Journal of Marketing, the International Journal of Research in Marketing, and the Journal of Marketing Research. He is also on the editorial boards of several academic journals. Dr. Parker received his Ph.D. in Business Economics from the Wharton School of the University of Pennsylvania and has Masters degrees in Finance and Banking (University of Aix-Marseille) and Managerial Economics (Wharton). His undergraduate degrees are in mathematics, biology and economics (minor in aeronautical engineering). He has consulted and/or taught courses in Africa, the Middle East, Asia, Latin America, North America and Europe.
About this Series This series was created for international firms who rely on foreign markets for a substantial portion of their business or who might be threatened by international competition. The estimates given in this report were created using a methodology developed by and implemented under the direct supervision of Professor Philip M. Parker, the Eli Lilly Chaired Professor of Innovation, Business and Society, at INSEAD. The methodology relies on historical figures across countries. Reported figures should be seen as estimates of past and future levels of latent demand.
Acknowledgements Some of the methodologies and research approaches used in this report have benefited from the R&D Committee at INSEAD, whose research support is gratefully acknowledged.
www.icongrouponline.com
Ó2003 ICON Group Ltd.
iv
About ICON Group Ltd. ICON Group Ltd.’s primary mission is to assist managers with their international information needs. U.S.-owned and operated, ICON Group has field offices in Paris, Hong Kong and Lomé, Togo (West Africa). Created in 1994, ICON Group has published hundreds of multi-client databases, and global/regional market data, industry and country publications. Global/Regional Management Studies. Summarizing over 190 countries, management studies are generally organized into regional volumes and cover key management functions. The human resource series covers minimum wages, child labor, unionization and collective bargaining. The international law series covers media control and censorship, search and seizure, and trial justice and punishment. The diversity management series covers a variety of environmental context drivers that effect global operations. These include women’s rights, children’s rights, discrimination/racism, and religious forces and risks. Global strategic planning studies cover economic risk assessments, political risk assessments, foreign direct investment strategy, intellectual property strategy, and export strategies. Financial management studies cover taxes and tariffs. Global marketing studies focus on target segments (e.g. seniors, children, women) and strategic marketing planning. Country Studies: Often managers need an in-depth, yet broad and up-to-date understanding of a country’s strategic market potential and situation before the first field trip or investment proposal. There are over 190 country studies available. Each study consists of analysis, statistics, forecasts, and information of relevance to managers. The studies are continually updated to insure that the reports have the most relevant information available. In addition to raw information, the reports provide relevant analyses which put a more general perspective on a country (seen in the context of relative performance vis-à-vis benchmarks). Industry Studies: Companies are racing to become more international, if not global in their strategies. For over 2000 product/industry categories, these reports give the reader a concise summary of latent market forecasts, pro-forma financials, import competition profiles, contacts, key references and trends across 200 countries of the world. Some reports focus on a particular product and region (up to four regions per product), while others focus on a product within a particular country.
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Contents
v
Table of Contents 1
INTRODUCTION
1.1 1.2 1.3 1.3.1 1.3.2 1.3.3 1.3.4 1.3.5 1.3.6 1.3.7
2
Step 1. Product Definition and Data Collection Step 2. Filtering and Smoothing Step 3. Filling in Missing Values Step 4. Varying Parameter, Non-linear Estimation Step 5. Fixed-Parameter Linear Estimation Step 6. Aggregation and Benchmarking Step 7. Latent Demand Density: Allocating Across Cities
SUMMARY OF FINDINGS
2.1 3
Overview What is Latent Demand and the P.I.E.? The Methodology
The Worldwide Market Potential for Biotechnology
AFRICA: BIOTECHNOLOGY
3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29
Executive Summary Algeria Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde Central African Republic Chad Comoros Congo (formerly Zaire) Ivory coast Djibouti Egypt Equatorial Guinea Ethiopia Gabon Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Libya Madagascar Malawi Mali
www.icongrouponline.com
11
11 11 12 14 16 16 16 17 17 17
19
19 21
21 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 Ó2003 ICON Group Ltd.
Contents
3.30 3.31 3.32 3.33 3.34 3.35 3.36 3.37 3.38 3.39 3.40 3.41 3.42 3.43 3.44 3.45 3.46 3.47 3.48 3.49 3.50 3.51 3.52 3.53 3.54 4
Mauritania Mauritius Morocco Mozambique Namibia Niger Nigeria Republic of Congo Reunion Rwanda Sao Tome E Principe Senegal Sierra Leone Somalia South Africa Sudan Swaziland Tanzania The Gambia Togo Tunisia Uganda Western Sahara Zambia Zimbabwe
ASIA: BIOTECHNOLOGY
4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18
Executive Summary Bangladesh Bhutan Brunei Burma Cambodia China Hong Kong India Indonesia Japan Laos Macau Malaysia Maldives Mongolia Nepal North Korea
www.icongrouponline.com
vi
51 52 53 54 55 56 57 58 59 60 61 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75
75 77 78 79 80 81 81 82 83 84 85 86 87 88 89 89 90 91 Ó2003 ICON Group Ltd.
Contents
4.19 4.20 4.21 4.22 4.23 4.24 4.25 4.26 4.27 5
vii
Papua New Guinea Philippines Seychelles Singapore South Korea Sri Lanka Taiwan Thailand Vietnam
92 93 94 95 95 96 97 98 99
EUROPE: BIOTECHNOLOGY
101
5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 5.19 5.20 5.21 5.22 5.23 5.24 5.25 5.26 5.27 5.28 5.29 5.30 5.31 5.32 5.33 5.34
Executive Summary Albania Andorra Austria Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Denmark Estonia Finland France Georgia Germany Greece Hungary Iceland Ireland Italy Kazakhstan Latvia Liechtenstein Lithuania Luxembourg Malta Moldova Monaco Netherlands Norway Poland Portugal Romania
www.icongrouponline.com
101 103 104 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 129 130 131 132 133 Ó2003 ICON Group Ltd.
Contents
5.35 5.36 5.37 5.38 5.39 5.40 5.41 5.42 5.43 6
LATIN AMERICA: BIOTECHNOLOGY
6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 6.10 6.11 6.12 6.13 6.14 6.15 6.16 6.17 6.18 6.19 6.20 6.21 6.22 6.23 7
Russia San Marino Slovakia Slovenia Spain Sweden Switzerland Ukraine United Kingdom Executive Summary Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Falkland Islands French Guiana Guatemala Guyana Honduras Mexico Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela
NORTH AMERICA & THE CARIBBEAN: BIOTECHNOLOGY
7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9
Executive Summary Antigua and Barbuda Aruba Bahamas Barbados Bermuda Canada Cayman Islands Cuba
www.icongrouponline.com
viii
134 135 136 137 138 139 140 141 142 143
143 145 146 147 148 149 150 151 152 153 154 154 155 156 157 158 159 160 161 162 163 164 165 166
166 168 168 169 170 170 171 172 173 Ó2003 ICON Group Ltd.
Contents
7.10 7.11 7.12 7.13 7.14 7.15 7.16 7.17 7.18 7.19 7.20 7.21 7.22 7.23 7.24 7.25 8
OCEANA: BIOTECHNOLOGY
8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.11 8.12 8.13 8.14 8.15 8.16 9
Dominica Dominican Republic Greenland Grenada Guadeloupe Haiti Jamaica Martinique Netherlands Antilles Puerto Rico St. Kitts and Nevis St. Lucia St. Vincent and the Grenadines Trinidad and Tobago United States Virgin Islands, US Executive Summary American Samoa Australia Fiji French Polynesia Guam Kiribati Nauru New Caledonia New Zealand Northern Mariana Island Solomon Islands Tonga Tuvalu Vanuatu Western Samoa
THE MIDDLE EAST: BIOTECHNOLOGY
9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9
Executive Summary Afghanistan Armenia Azerbaijan Bahrain Iran Iraq Israel Jordan
www.icongrouponline.com
ix
174 175 176 177 177 178 179 180 181 182 183 183 184 185 186 187 188
188 190 191 192 192 193 194 194 195 196 197 197 198 199 199 200 201
201 203 204 205 206 207 208 209 210 Ó2003 ICON Group Ltd.
Contents
9.10 9.11 9.12 9.13 9.14 9.15 9.16 9.17 9.18 9.19 9.20 9.21 9.22 9.23 10
Kuwait Kyrgyzstan Lebanon Oman Pakistan Qatar Saudi Arabia Syrian Arab Republic Tajikistan Turkey Turkmenistan United Arab Emirates Uzbekistan Yemen
211 212 213 214 215 216 216 217 218 219 220 221 222 223
DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
10.1 10.2
Disclaimers & Safe Harbor ICON Group Ltd. User Agreement Provisions
www.icongrouponline.com
x
224
224 225
Ó2003 ICON Group Ltd.
Biotechnology
11
1 INTRODUCTION 1.1 OVERVIEW This study covers the world outlook for biotechnology across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E. for biotechnology. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.
1.2 WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable or not yet realized. Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The “market” is defined at a given level in the value chain. There can be latent demand at the retail level, at the wholesale level, the manufacturing level, and the raw materials level (the P.I.E. of higher levels of the value chain being always smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for biotechnology is not actual or historic sales. Nor is latent demand future sales. In fact, latent demand can be lower either lower or higher than actual sales if a market is inefficient (i.e. not representative of relatively competitive levels). Inefficiencies arise from a www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
12
number of factors, including the lack of international openness, cultural barriers to consumption, regulations, and cartel-like behavior on the part of firms. In general, however, latent demand is typically larger than actual sales in a country market. For reasons discussed later, this report does not consider the notion of “unit quantities”, only total latent revenues (i.e. a calculation of price times quantity is never made, though one is implied). The units used in this report are U.S. dollars not adjusted for inflation (i.e. the figures incorporate inflationary trends) and not adjusted for future dynamics in exchange rates (i.e. the figures reflect average exchange rates over recent history). If inflation rates or exchange rates vary in a substantial way compared to recent experience, actually sales can also exceed latent demand (when expressed in U.S. dollars, not adjusted for inflation). On the other hand, latent demand can be typically higher than actual sales as there are often distribution inefficiencies that reduce actual sales below the level of latent demand. As mentioned in the introduction, this study is strategic in nature, taking an aggregate and longrun view, irrespective of the players or products involved. If fact, all the current products or services on the market can cease to exist in their present form (i.e. at a brand-, R&D specification, or corporate-image level) and all the players can be replaced by other firms (i.e. via exits, entries, mergers, bankruptcies, etc.), and there will still be an international latent demand for biotechnology at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand.
1.3 THE METHODOLOGY In order to estimate the latent demand for biotechnology on a worldwide basis, I used a multistage approach. Before applying the approach, one needs a basic theory from which such estimates are created. In this case, I heavily rely on the use of certain basic economic assumptions. In particular, there is an assumption governing the shape and type of aggregate latent demand functions. Latent demand functions relate the income of a country, city, state, household, or individual to realized consumption. Latent demand (often realized as consumption when an industry is efficient), at any level of the value chain, takes place if an equilibrium in realized. For firms to serve a market, they must perceive a latent demand and be able to serve that demand at a minimal return. The single most important variable determining consumption, assuming latent demand exists, is income (or other financial resources at higher levels of the value chain). Other factors that can pivot or shape demand curves include external or exogenous shocks (i.e. business cycles), and or changes in utility for the product in question. Ignoring, for the moment, exogenous shocks and variations in utility across countries, the aggregate relation between income and consumption has been a central theme in economics. The figure below concisely summarizes one aspect of problem. In the 1930s, John Meynard Keynes conjectured that as incomes rise, the average propensity to consume would fall. The average
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
13
propensity to consume is the level of consumption divided by the level of income, or the slope of the line from the origin to the consumption function. He estimated this relationship empirically and found it to be true in the short-run (mostly based on cross-sectional data). The higher the income, the lower the average propensity to consume. This type of consumption function is labeled "A" in the figure below (note the rather flat slope of the curve). In the 1940s, another macroeconomist, Simon Kuznets, estimated long-run consumption functions which indicated that the marginal propensity to consume was rather constant (using time series data across countries). This type of consumption function is show as "B" in the figure below (note the higher slope and zero-zero intercept).1 The average propensity to consume is constant.
Latent Demand
B
A
Income Is it declining or is it constant? A number of other economists, notably Franco Modigliani and Milton Friedman, in the 1950s (and Irving Fisher earlier), explained why the two functions were different using various assumptions on intertemporal budget constraints, savings, and wealth. The shorter the time horizon, the more consumption can depend on wealth (earned in previous years) and business cycles. In the long-run, however, the propensity to consume is more constant. Similarly, in the long run, households, industries or countries with no income eventually have no consumption (wealth is depleted). While the debate surrounding beliefs about how income and consumption are related and interesting, in this study a very particular school of thought is adopted. In particular, we are considering the latent demand for biotechnology across some 230 countries. The smallest have fewer than 10,000 inhabitants. I assume that all of these counties fall along a "long-run" aggregate consumption function. This long-run function applies despite some 1
For a general overview of this subject area, see Principles of Macroeconomics by N. Gregory Mankiw, SouthWestern College Publishing; ISBN: 0030340594; 2nd edition (February 2002). www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
14
of these countries having wealth, current income dominates the latent demand for biotechnology. So, latent demand in the long-run has a zero intercept. However, I allow firms to have different propensities to consume (including being on consumption functions with differing slopes, which can account for differences in industrial organization, and end-user preferences). Given this overriding philosophy, I will now describe the methodology used to create the latent demand estimates for biotechnology. Since ICON Group has asked me to apply this methodology to a large number of categories, the rather academic discussion below is general and can be applied to a wide variety of categories, not just biotechnology.
1.3.1
Step 1. Product Definition and Data Collection
Any study of latent demand across countries requires that some standard be established to define “efficiently served”. Having implemented various alternatives and matched these with market outcomes, I have found that the optimal approach is to assume that certain key countries are more likely to be at or near efficiency than others. These countries are given greater weight than others in the estimation of latent demand compared to other countries for which no known data are available. Of the many alternatives, I have found the assumption that the world’s highest aggregate income and highest income-per-capita markets reflect the best standards for “efficiency”. High aggregate income alone is not sufficient (i.e. China has high aggregate income, but low income per capita and can not assumed to be efficient). Aggregate income can be operationalized in a number of ways, including gross domestic product (for industrial categories), or total disposable income (for household categories; population times average income per capita, or number of households times average household income per capita). Brunei, Nauru, Kuwait, and Lichtenstein are examples of countries with high income per capita, but not assumed to be efficient, given low aggregate level of income (or gross domestic product); these countries have, however, high incomes per capita but may not benefit from the efficiencies derived from economies of scale associated with large economies. Only countries with high income per capita and large aggregate income are assumed efficient. This greatly restricts the pool of countries to those in the OECD (Organization for Economic Cooperation and Development), like the United States, or the United Kingdom (which were earlier than other large OECD economies to liberalize their markets). The selection of countries is further reduced by the fact that not all countries in the OECD report industry revenues at the category level. Countries that typically have ample data at the aggregate level that meet the efficiency criteria include the United States, the United Kingdom and in some cases France and Germany. Latent demand is therefore estimated using data collected for relatively efficient markets from independent data sources (e.g. Euromonitor, Mintel, Thomson Financial Services, the U.S. Industrial Outlook, the World Resources Institute, the Organization for Economic Cooperation and Development, various agencies from the United Nations, industry trade associations, the International Monetary Fund, and the World Bank). Depending on original data sources used, the www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
15
definition of “biotechnology” is established. In the case of this report, the data were reported at the aggregate level, with no further breakdown or definition. In other words, any potential product or service that might be incorporated within biotechnology falls under this category. Public sources rarely report data at the disaggregated level in order to protect private information from individual firms that might dominate a specific product-market. These sources will therefore aggregate across components of a category and report only the aggregate to the public. While private data are certainly available, this report only relies on public data at the aggregate level without reliance on the summation of various category components. In other words, this report does not aggregate a number of components to arrive at the “whole”. Rather, it starts with the “whole”, and estimates the whole for all countries and the world at large (without needing to know the specific parts that went into the whole in the first place). Given this caveat, this study covers “biotechnology” as defined by the Standard Industrial Classification code system used in various U.S. government sources. In spite of the more recent system North American Industrial Classification system or NAICs (pronounced “nakes”), the SIC system is still in use in various publications that estimate industrial output. For a complete definition of biotechnology, please refer to the Web site at: http://155.103.6.10/cgibin/sic/sicser2?8731, maintained by the U.S. government. The SIC for biotechnology is 8731. It is for this definition of biotechnology that the aggregate latent demand estimates are derived.
SIC Description for 8731 8731: Commercial Physical and Biological Research Establishments primarily engaged in commercial physical and biological research and development on a contract or fee basis. Noncommercial research establishments funded by endowments, grants, or contributions are classified in Industry 8733. Separate establishments of aircraft, guided missile, or spacecraft manufacturers primarily engaged in research and development on these products are classified in Manufacturing, Major Group 37. · Agricultural research, · Biological research commercial · Chemical laboratories, commercial research except testing · Engineering laboratories, commercial research: except testing · Food research commercial · Industrial laboratories commercial research: except testing · Physical research commercial · Research and development physical and biological: commercial
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
1.3.2
16
Step 2. Filtering and Smoothing
Based on the aggregate view of biotechnology as defined above, data were then collected for as many similar countries as possible for that same definition, at the same level of the value chain. This generates a convenience sample of countries from which comparable figures are available. If the series in question do not reflect the same accounting period, then adjustments are made. In order to eliminate short-term effects of business cycles, the series are smoothed using an 2 year moving average weighting scheme (longer weighting schemes do not substantially change the results). If data are available for a country, but these reflect short-run aberrations due to exogenous shocks (such as would be the case of beef sales in a country stricken with foot and mouth disease), these observations were dropped or "filtered" from the analysis.
1.3.3
Step 3. Filling in Missing Values
In some cases, data are available for countries on a sporadic basis. In other cases, data from a country may be available for only one year. From a Bayesian perspective, these observations should be given greatest weight in estimating missing years. Assuming that other factors are held constant, the missing years are extrapolated using changes and growth in aggregate national income. Based on the overriding philosophy of a long-run consumption function (defined earlier), countries which have missing data for any given year, are estimated based on historical dynamics of aggregate income for that country.2
1.3.4
Step 4. Varying Parameter, Non-linear Estimation
Given the data available from the first three steps, the latent demand in additional countries is estimated using a “varying-parameter cross-sectionally pooled time series model”.3 Simply stated, the effect of income on latent demand is assumed to be constant across countries unless there is empirical evidence to suggest that this effect varies (i.e. . the slope of the income effect is not necessarily same for all countries). This assumption applies across countries along the aggregate consumption function, but also over time (i.e. not all countries are perceived to have the same income growth prospects over time and this effect can vary from country to country as 2
This report was prepared from a variety of sources including excerpts from documents and official reports or databases published by the World Bank, the U.S. Department of Commerce, the U.S. State Department, various national agencies, the International Monetary Fund, the Central Intelligence Agency, various agencies from the United Nations (e.g. ILO, ITU, UNDP, etc.), and non-governmental sources, including ICON Group Ltd., Euromonitor, the World Resources Institute, Mintel, the U.S. Industrial Outlook, and various public sources cited in the trade press. 3 The interested reader can find longer discussions of this type of modeling in Studies in Global Econometrics (Advanced Studies in Theoretical and Applied Econometrics V. 30), by Henri Theil, et al., Kluwer Academic Publishers; ISBN: 0792336607; (June 1996), and in Principles of Econometrics, by Henri Theil John Wiley & Sons; ISBN: 0471858455; (December 1971), and in Econometric Models and Economic Forecasts by Robert S. Pindyck, Daniel L. Rubinfeld McGraw Hill Text; ISBN: 0070500983; 3rd edition (December 1991). www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
17
well). Another way of looking at this is to say that latent demand for biotechnology is more likely to be similar across countries that have similar characteristics in terms of economic development (i.e. African countries will have similar latent demand structures controlling for the income variation across the pool of African countries). This approach is useful across countries for which some notion of non-linearity exists in the aggregate cross-country consumption function. For some categories, however, the reader must realize that the numbers will reflect a country’s contribution to global latent demand and may never be realized in the form of local sales. For certain country-category combinations this will result in what at first glance will be odd results. For example, the latent demand for the category “space vehicles” will exist for “Togo” even though they have no space program. The assumption is that if the economies in these countries did not exist, the world aggregate for these categories would be lower. The share attributed to these countries is based on a proportion of their income (however small) being used to consume the category in question (i.e. perhaps via resellers).
1.3.5
Step 5. Fixed-Parameter Linear Estimation
Nonlinearities are assumed in cases where filtered data exist along the aggregate consumption function. Because the world consists of more than 200 countries, there will always be those countries, especially toward the bottom of the consumption function, where non-linear estimation is simply not possible. For these countries, equilibrium latent demand is assumed to be perfectly parametric and not a function of wealth (i.e. a country’s stock of income), but a function of current income (a country’s flow of income). In the long run, if a country has no current income, the latent demand for biotechnology is assumed to approach zero. The assumption is that wealth stocks fall rapidly to zero if flow income falls to zero (i.e. countries which earn low levels of income will not use their savings, in the long run, to demand biotechnology). In a graphical sense, for low income countries, latent demand approaches zero in a parametric linear fashion with a zero-zero intercept. In this stage of the estimation procedure, low-income countries are assumed to have a latent demand proportional to their income, based on the country closest to it on the aggregate consumption function.
1.3.6
Step 6. Aggregation and Benchmarking
Based on the models described above, latent demand figures are estimated for all countries of the world, including for the smallest economies. These are then aggregated to get world totals and regional totals. To make the numbers more meaningful, regional and global demand averages are presented. Figures are rounded, so minor inconsistencies may exist across tables.
1.3.7
Step 7. Latent Demand Density: Allocating Across Cities
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
18
With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report also covers the world’s top 2000 cities. The purpose is to understand the density of demand within a country and the extent to which a city might be used as a point of distribution within its region. From an economic perspective, however, a city does not represent a population within rigid geographical boundaries. To an economist or strategic planner, a city represents an area of dominant influence over markets in adjacent areas. This influence varies from one industry to another, but also from one period of time to another. Similar to country-level data, the reader needs to realize that latent demand allocated to a city may or may not represent real sales. For many items, latent demand is clearly observable in sales, as in the case for food or housing items. Consider, again, the category “satellite launch vehicles.” Clearly, there are no launch pads in most cities of the world. However, the core benefit of the vehicles (e.g. telecommunications, etc.) is "consumed" by residents or industries within the world's cities. Without certain cities, in other words, the world market for satellite launch vehicles would be lower for the world in general. One needs to allocate, therefore, a portion of the worldwide economic demand for launch vehicles to regions, countries and cities. This report takes the broader definition and considers, therefore, a city as a part of the global market. I allocate latent demand across areas of dominant influence based on the relative economic importance of cities within its home country, within its region and across the world total. Not all cities are estimated within each country as demand may be allocated to adjacent areas of influence. Since some cities have higher economic wealth than others within the same country, a city’s population is not generally used to allocate latent demand. Rather, the level of economic activity of the city vis-à-vis others.
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
19
2 SUMMARY OF FINDINGS Based on the methodology described above, the latent demand for biotechnology is estimated to be $28.7 billion in 2003. The distribution of the world latent demand (or potential industry earnings), however, is not be evenly distributed across regions. North America & the Caribbean is the largest market with $28.5 billion or 99.26 percent, followed by Asia with $0.1 billion or 0.32 percent, and then Europe with $0.1 billion or 0.25 percent of the world market. In essence, if firms target these top 3 regions, they cover come 99.83 percent of the global latent demand for biotechnology.
2.1 THE WORLDWIDE MARKET POTENTIAL FOR BIOTECHNOLOGY Worldwide Market Potential for Biotechnology (US $ mln): 2003 Region
Latent Demand US $ mln
% of Globe
_________________________________________________________________________________________________________
North America & the Caribbean Asia Europe Latin America Middle East Africa Oceana Total
28,490 91 72 23 12 11 4 28,702
99.3 0.3 0.3 0.1 0.0 0.0 0.0 100.0
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Worldwide Market Potential for Biotechnology (US $ mln): 2003
Asia Europe North America & the Caribbean
Latin America Other
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
20
World Market for Biotechnology: 1998 - 2008 Year
World Market US $ mln
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
17,863.34 19,637.85 21,589.54 23,736.12 26,098.04 28,701.69 31,566.35 34,717.11 38,182.55 41,994.12 46,186.41
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
21
3 AFRICA: BIOTECHNOLOGY 3.1
EXECUTIVE SUMMARY Market Potential for Biotechnology in Africa (US $ mln): 2003
Country
Latent Demand US $ mln
% of Africa
2 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 11
22.04% 14.90% 10.31% 7.01% 6.21% 3.79% 2.76% 2.69% 2.33% 2.23% 2.17% 1.69% 1.61% 1.59% 1.56% 1.54% 1.52% 1.15% 0.97% 0.75% 0.74% 0.72% 0.63% 0.61% 0.60% 7.88% 100.00%
_________________________________________________________________________________________________________
South Africa Egypt Algeria Nigeria Morocco Tunisia Libya Kenya Ethiopia Ghana Sudan Congo (formerly Zaire) Zimbabwe Uganda Cameroon Ivory coast Tanzania Mozambique Senegal Mauritius Madagascar Burkina Faso Botswana Angola Guinea Other Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
22
Market Potential for Biotechnology in Africa (US $ mln): 2003 Algeria
Nigeria
Egypt
Other South Africa
The Market for Biotechnology in Africa: 1998 - 2008 Year
US $ mln
% of Globe
9.28 9.54 9.82 10.11 10.46 11.11 11.85 12.65 13.50 14.41 15.39
0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.2
23
ALGERIA Biotechnology (US $ mln): Algeria 1998 - 2008
Year
Algeria
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 2 2
10.57% 10.49% 10.40% 10.32% 10.25% 10.31% 10.39% 10.47% 10.54% 10.61% 10.69%
0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Algeria: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
148 262 365 474 704 721 726 773 841 843 845 891 929
0.41 0.17 0.12 0.08 0.05 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 1.15
36.17 15.09 10.58 7.34 4.37 4.10 4.08 3.67 3.12 3.10 3.05 2.76 2.57 100.00
3.73 1.56 1.09 0.76 0.45 0.42 0.42 0.38 0.32 0.32 0.31 0.28 0.26 10.31
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Algiers Oran Constantine Annaba Batna Blida Setif Sidi-Bel-Abbes Ech-Cheliff Skikda Tlemcen Bejaia Bechar Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.3
24
ANGOLA Biotechnology (US $ mln): Angola 1998 - 2008
Year
Angola
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.62% 0.62% 0.61% 0.61% 0.61% 0.61% 0.61% 0.62% 0.62% 0.63% 0.63%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Angola: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
682 1,686 1,704 1,797 1,805 1,869 1,897
0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.07
78.48 5.65 5.38 3.34 3.23 2.21 1.72 100.00
0.48 0.03 0.03 0.02 0.02 0.01 0.01 0.61
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Luanda Lubango Namibe Huambo Lobito Benguela Malanje Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.4
25
BENIN Biotechnology (US $ mln): Benin 1998 - 2008
Year
Benin
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.41% 0.40% 0.40% 0.40% 0.40% 0.40% 0.40% 0.40% 0.41% 0.41% 0.41%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Benin: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,002 1,373 1,726 1,766 1,770
0.02 0.01 0.00 0.00 0.00 0.04
56.24 24.02 7.62 6.24 5.89 100.00
0.22 0.10 0.03 0.02 0.02 0.40
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Cotonou Porto-Novo Parakou Abomey Natitingou Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.5
26
BOTSWANA Biotechnology (US $ mln): Botswana 1998 - 2008
Year
Botswana
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.66% 0.65% 0.64% 0.63% 0.62% 0.63% 0.64% 0.65% 0.65% 0.66% 0.67%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Botswana: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,327 1,366 1,408 1,431 1,571 1,594 1,613 1,762 1,799 1,810 1,831 1,857 1,879
0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07
17.02 15.49 14.26 13.04 8.28 7.52 7.06 3.99 3.22 3.07 2.76 2.30 1.99 100.00
0.11 0.10 0.09 0.08 0.05 0.05 0.04 0.03 0.02 0.02 0.02 0.01 0.01 0.63
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Gaborone Mahalapye Serowe Tutume Bobonong Francistown Selebi-Phikwe Lobatse Molepolole Kanye Mochudi Maun Ramotswa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.6
27
BURKINA FASO Biotechnology (US $ mln): Burkina Faso 1998 - 2008
Year
Burkina Faso
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.74% 0.74% 0.73% 0.72% 0.72% 0.72% 0.73% 0.73% 0.74% 0.74% 0.75%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Burkina Faso: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
762 1,038 1,606 1,688 1,721 1,776
0.04 0.02 0.01 0.00 0.00 0.00 0.08
53.58 28.00 6.30 4.73 4.24 3.15 100.00
0.39 0.20 0.05 0.03 0.03 0.02 0.72
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Ouagadougou Bobo-Dioulasso Koudougou Ouahigouya Banfora Kaya Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.7
28
BURUNDI Biotechnology (US $ mln): Burundi 1998 - 2008
Year
Burundi
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.25% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.25% 0.25%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Burundi: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,069 1,514 1,976 2,006 2,025
0.02 0.01 0.00 0.00 0.00 0.03
70.91 24.68 2.08 1.30 1.04 100.00
0.19 0.06 0.01 0.00 0.00 0.26
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Bujumbura Gitega Bururi Rumonge Ngozi Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.8
29
CAMEROON Biotechnology (US $ mln): Cameroon 1998 - 2008
Year
Cameroon
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.59% 1.58% 1.57% 1.56% 1.56% 1.56% 1.57% 1.58% 1.58% 1.59% 1.60%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Cameroon: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
496 693 1,477 1,490 1,504 1,586 1,678 1,718 1,748 1,788
0.08 0.05 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.17
46.52 29.65 4.66 4.41 4.25 3.17 2.25 2.00 1.71 1.37 100.00
0.73 0.46 0.07 0.07 0.07 0.05 0.04 0.03 0.03 0.02 1.56
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Douala Yaounde Nkongsamba Maroua Garoua Bafoussam Kumba Bamenda Foumban Limbe Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
3.9
30
CAPE VERDE Biotechnology (US $ mln): Cape Verde 1998 - 2008
Year
Cape Verde
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Cape Verde: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,781 1,841 2,056 2,063 2,064
0.00 0.00 0.00 0.00 0.00 0.00
54.95 40.66 2.20 1.10 1.10 100.00
0.02 0.02 0.00 0.00 0.00 0.04
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Praia Mindelo Ribeira Grande Santa Maria Sal Rei Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
31
3.10 CENTRAL AFRICAN REPUBLIC Biotechnology (US $ mln): Central African Republic 1998 - 2008 Year
Central African Republic
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Central African Republic: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
954 1,633 1,771 1,786 1,852 1,885
0.03 0.00 0.00 0.00 0.00 0.00 0.04
68.70 11.51 6.33 5.98 4.14 3.34 100.00
0.25 0.04 0.02 0.02 0.02 0.01 0.37
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Bangui Berberati Bouar Bambari Bangassou Mbaiki Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
32
3.11 CHAD Biotechnology (US $ mln): Chad 1998 - 2008 Year
Chad
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Chad: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
965 1,540 1,638 1,692 1,703 1,723 1,744 1,909 1,921
0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05
50.05 12.12 8.50 6.94 6.74 6.26 5.67 1.96 1.76 100.00
0.24 0.06 0.04 0.03 0.03 0.03 0.03 0.01 0.01 0.49
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
N'Djamena Sarh Moundou Abeche Bongor Doba Lai Koumra Kelo Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
33
3.12 COMOROS Biotechnology (US $ mln): Comoros 1998 - 2008 Year
Comoros
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Comoros: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,887 1,935 2,004 2,038
0.00 0.00 0.00 0.00 0.00
48.84 30.23 13.95 6.98 100.00
0.01 0.01 0.00 0.00 0.02
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Moroni Mutsamudu Fomboni Mitsamiouli Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
34
3.13 CONGO (FORMERLY ZAIRE) Biotechnology (US $ mln): Congo (formerly Zaire) 1998 - 2008 Year
Congo (formerly Zaire)
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.25% 1.38% 1.52% 1.68% 1.81% 1.69% 1.55% 1.41% 1.29% 1.18% 1.08%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Congo (formerly Zaire): Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
440 1,094 1,222 1,392 1,407 1,530 1,560 1,561 1,576 1,599 1,604 1,649
0.09 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.19
50.00 10.23 7.97 5.48 5.33 3.65 3.24 3.22 3.01 2.77 2.73 2.35 100.00
0.85 0.17 0.14 0.09 0.09 0.06 0.05 0.05 0.05 0.05 0.05 0.04 1.69
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Kinshasa Lubumbashi Mbuji-Mayi Kananga Kisangani Likasi Kalemie Bukavu Kamina Kikwit Matadi Mbandaka Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
35
3.14 IVORY COAST Biotechnology (US $ mln): Ivory coast 1998 - 2008 Year
Ivory coast
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.45% 1.48% 1.51% 1.54% 1.56% 1.54% 1.51% 1.49% 1.46% 1.43% 1.41%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Cote d'Ivoire: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
350 1,215 1,468 1,584 1,664 1,690 1,701 1,751
0.13 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.17
74.60 8.87 4.84 3.23 2.42 2.22 2.14 1.69 100.00
1.15 0.14 0.07 0.05 0.04 0.03 0.03 0.03 1.54
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Abidjan Bouake Yamoussoukro Daloa Port-Bouet Man Korhogo Gagnoa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
36
3.15 DJIBOUTI Biotechnology (US $ mln): Djibouti 1998 - 2008 Year
Djibouti
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Djibouti: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,777 2,003 2,024 2,026 2,027
0.00 0.00 0.00 0.00 0.00 0.00
66.67 10.11 8.05 7.82 7.36 100.00
0.02 0.00 0.00 0.00 0.00 0.03
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Djibouti Dikhil Tadjourah Ali-Sabiah Obock Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
37
3.16 EGYPT Biotechnology (US $ mln): Egypt 1998 - 2008 Year
Egypt
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 2 2 2 2 2 2 2 2
15.27% 15.15% 15.03% 14.90% 14.81% 14.90% 15.01% 15.12% 15.23% 15.33% 15.44%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Egypt: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
80 196 297 850 855 866 883 893 979 1,006 1,020 1,136
0.99 0.26 0.15 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 1.65
59.57 15.80 9.05 2.09 2.07 2.03 1.94 1.91 1.58 1.48 1.44 1.06 100.00
8.87 2.35 1.35 0.31 0.31 0.30 0.29 0.28 0.23 0.22 0.21 0.16 14.90
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Cairo Alexandria Giza Al-Mahallah al Kubra Port Said Tanta Al-Mansurah Helwan Asyut Zagazig Suez Aswan Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
38
3.17 EQUATORIAL GUINEA Biotechnology (US $ mln): Equatorial Guinea 1998 - 2008 Year
Equatorial Guinea
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.07% 0.07% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.07% 0.07% 0.07%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Equatorial Guinea: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,740 1,867 1,898 1,932
0.00 0.00 0.00 0.00 0.01
47.24 22.83 17.32 12.60 100.00
0.03 0.01 0.01 0.01 0.06
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Malabo Bata Luba Mbini Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
39
3.18 ETHIOPIA Biotechnology (US $ mln): Ethiopia 1998 - 2008 Year
Ethiopia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
2.28% 2.30% 2.31% 2.33% 2.34% 2.33% 2.32% 2.30% 2.28% 2.27% 2.25%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Ethiopia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
274 885 1,378 1,449 1,473 1,474 1,529 1,532 1,539 1,567 1,656
0.16 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.26
62.14 12.30 4.07 3.37 3.16 3.16 2.66 2.62 2.58 2.29 1.66 100.00
1.45 0.29 0.09 0.08 0.07 0.07 0.06 0.06 0.06 0.05 0.04 2.33
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Addis Ababa Asmera Dire Dawa Gondar Dessye Nazret Jimma Harar Mekele Bahr Dar Debre Markos Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
40
3.19 GABON Biotechnology (US $ mln): Gabon 1998 - 2008 Year
Gabon
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.44% 0.45% 0.45% 0.46% 0.46% 0.46% 0.45% 0.45% 0.44% 0.44% 0.43%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Gabon: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
908 1,247 1,808 1,883 1,891 1,896
0.03 0.01 0.00 0.00 0.00 0.00 0.05
60.07 27.99 4.27 2.73 2.56 2.39 100.00
0.27 0.13 0.02 0.01 0.01 0.01 0.46
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Libreville Port Gentil Lambarene Mouila Tchibanga Oyem Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
41
3.20 GHANA Biotechnology (US $ mln): Ghana 1998 - 2008 Year
Ghana
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
2.22% 2.22% 2.23% 2.23% 2.24% 2.23% 2.23% 2.23% 2.22% 2.22% 2.21%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Ghana: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
359 705 1,090 1,252 1,274 1,494 1,495 1,609 1,618 1,666
0.12 0.05 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.25
49.30 20.00 7.84 5.66 5.40 3.06 3.06 2.03 1.97 1.66 100.00
1.10 0.45 0.18 0.13 0.12 0.07 0.07 0.05 0.04 0.04 2.23
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Accra Kumasi Tamale Tema Sekondi-Takoradi Cape Coast Koforidua Sunyani Ho Bolgatanga Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
42
3.21 GUINEA Biotechnology (US $ mln): Guinea 1998 - 2008 Year
Guinea
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.62% 0.61% 0.61% 0.60% 0.60% 0.60% 0.61% 0.61% 0.62% 0.62% 0.62%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Guinea: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
678 1,534 1,614 1,847
0.05 0.01 0.00 0.00 0.07
79.93 10.09 7.37 2.61 100.00
0.48 0.06 0.04 0.02 0.60
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Conakry Kankan Labe Nzerekore Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
43
3.22 GUINEA-BISSAU Biotechnology (US $ mln): Guinea-Bissau 1998 - 2008 Year
Guinea-Bissau
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Guinea-Bissau: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,577 1,979 2,013 2,032 2,033 2,034 2,039
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01
75.76 7.88 4.85 3.03 3.03 3.03 2.42 100.00
0.05 0.01 0.00 0.00 0.00 0.00 0.00 0.07
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Bissau Bafata Gabu Mansoa Catio Cantchungo Farim Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
44
3.23 KENYA Biotechnology (US $ mln): Kenya 1998 - 2008 Year
Kenya
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
2.56% 2.60% 2.65% 2.69% 2.72% 2.69% 2.65% 2.61% 2.58% 2.54% 2.50%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Kenya: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
270 601 998 1,207 1,435 1,556 1,590 1,798 1,814 1,845 1,855
0.17 0.06 0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.30
55.53 21.43 8.40 5.13 3.02 2.06 1.81 0.75 0.70 0.60 0.55 100.00
1.49 0.58 0.23 0.14 0.08 0.06 0.05 0.02 0.02 0.02 0.01 2.69
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Nairobi Mombasa Kisumu Nakuru Eldoret Thika Nyeri Nanyuki Kitale Malindi Kericho Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
45
3.24 LESOTHO Biotechnology (US $ mln): Lesotho 1998 - 2008 Year
Lesotho
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Lesotho: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
936 1,813 1,863 1,890
0.03 0.00 0.00 0.00 0.03
85.16 6.25 4.69 3.91 100.00
0.26 0.02 0.01 0.01 0.30
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Maseru Teyateyaneng Leribe Mafeteng Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
46
3.25 LIBERIA Biotechnology (US $ mln): Liberia 1998 - 2008 Year
Liberia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.25% 0.24% 0.23% 0.21% 0.20% 0.21% 0.22% 0.24% 0.25% 0.26% 0.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Liberia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,112 1,754 1,911 1,971 1,988
0.02 0.00 0.00 0.00 0.00 0.02
78.41 12.18 4.43 2.77 2.21 100.00
0.17 0.03 0.01 0.01 0.00 0.21
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Monrovia Harbel Buchanan Tubmanburg Harper Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
47
3.26 LIBYA Biotechnology (US $ mln): Libya 1998 - 2008 Year
Libya
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
2.89% 2.85% 2.80% 2.76% 2.73% 2.76% 2.80% 2.84% 2.88% 2.92% 2.96%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Libya: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
283 492 1,042 1,202 1,570 1,578 1,588 1,593 1,605 1,641
0.16 0.08 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.31
50.89 26.45 7.24 5.04 1.90 1.84 1.78 1.72 1.66 1.48 100.00
1.40 0.73 0.20 0.14 0.05 0.05 0.05 0.05 0.05 0.04 2.76
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Tripoli Benghazi Misurata Az Zawiyah Al-Bayda Ajdabiya Darnah Sebha Tubruq Al-Marj Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
48
3.27 MADAGASCAR Biotechnology (US $ mln): Madagascar 1998 - 2008 Year
Madagascar
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.76% 0.75% 0.75% 0.74% 0.74% 0.74% 0.75% 0.75% 0.76% 0.76% 0.76%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Madagascar: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
732 1,432 1,510 1,511 1,601 1,683 1,717
0.05 0.01 0.01 0.01 0.01 0.00 0.00 0.08
56.02 11.08 8.84 8.84 6.29 4.70 4.22 100.00
0.42 0.08 0.07 0.07 0.05 0.03 0.03 0.74
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Antananarivo Toamasina Mahajanga Fianarantsoa Antsirabe Toliara Antsiranana Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
49
3.28 MALAWI Biotechnology (US $ mln): Malawi 1998 - 2008 Year
Malawi
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Malawi: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
899 1,166 1,447 1,669 1,914 1,931
0.03 0.02 0.01 0.00 0.00 0.00 0.06
49.45 26.99 14.11 6.50 1.60 1.35 100.00
0.28 0.15 0.08 0.04 0.01 0.01 0.56
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Blantyre Lilongwe Mzuzu Zomba Karonga Nkhotakota Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
50
3.29 MALI Biotechnology (US $ mln): Mali 1998 - 2008 Year
Mali
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.56% 0.56% 0.55% 0.55% 0.55% 0.55% 0.55% 0.56% 0.56% 0.56% 0.57%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Mali: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
759 1,653 1,708 1,738 1,747 1,815 1,888
0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.06
71.15 7.16 5.95 5.18 4.96 3.41 2.20 100.00
0.39 0.04 0.03 0.03 0.03 0.02 0.01 0.55
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Bamako Segou Mopti Sikasso Kayes Gao Timbuktu Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
51
3.30 MAURITANIA Biotechnology (US $ mln): Mauritania 1998 - 2008 Year
Mauritania
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.33% 0.33% 0.33% 0.33% 0.32% 0.33% 0.33% 0.33% 0.33% 0.34% 0.34%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Mauritania: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
918 1,889 1,892 1,912 1,916 1,917 1,967
0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.04
82.92 3.65 3.48 2.82 2.65 2.65 1.82 100.00
0.27 0.01 0.01 0.01 0.01 0.01 0.01 0.33
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Nouakchott Nouadhibou Kaedi Zouerate Rosso Atar Kiffa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
52
3.31 MAURITIUS Biotechnology (US $ mln): Mauritius 1998 - 2008 Year
Mauritius
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.80% 0.78% 0.77% 0.75% 0.74% 0.75% 0.77% 0.78% 0.79% 0.81% 0.82%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Mauritius: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
957 1,108 1,285 1,286 1,357
0.03 0.02 0.01 0.01 0.01 0.08
33.33 22.30 15.59 15.59 13.19 100.00
0.25 0.17 0.12 0.12 0.10 0.75
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Port Louis Beau Bassin Quatre Bornes Curepipe Vacoas-Phoenix Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
53
3.32 MOROCCO Biotechnology (US $ mln): Morocco 1998 - 2008 Year
Morocco
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
5.95% 6.04% 6.12% 6.20% 6.26% 6.21% 6.13% 6.06% 5.98% 5.90% 5.83%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Morocco: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
266 478 540 666 690 708 723 730 784 787 923
0.17 0.08 0.08 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.03 0.69
24.65 12.09 10.92 7.92 7.60 7.07 6.79 6.73 5.97 5.94 4.32 100.00
1.53 0.75 0.68 0.49 0.47 0.44 0.42 0.42 0.37 0.37 0.27 6.21
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Casablanca Marrakech Rabat Fez Oujda Kenitra Tetouan Safi Meknes Agadir Tangier Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
54
3.33 MOZAMBIQUE Biotechnology (US $ mln): Mozambique 1998 - 2008 Year
Mozambique
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.15% 1.15% 1.15% 1.15% 1.14% 1.15% 1.15% 1.15% 1.15% 1.15% 1.15%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Mozambique: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
522 1,058 1,244 1,505 1,731 1,837 1,838
0.08 0.02 0.01 0.01 0.00 0.00 0.00 0.13
60.83 16.60 11.20 5.80 2.62 1.48 1.48 100.00
0.70 0.19 0.13 0.07 0.03 0.02 0.02 1.15
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Maputo Beira Nampula Nacala Machaze Mandie Chibuto Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
55
3.34 NAMIBIA Biotechnology (US $ mln): Namibia 1998 - 2008 Year
Namibia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Namibia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
840 1,670 1,720 1,760 1,780 1,806
0.04 0.00 0.00 0.00 0.00 0.00 0.05
70.55 7.98 6.75 5.52 4.91 4.29 100.00
0.32 0.04 0.03 0.03 0.02 0.02 0.46
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Windhoek Tsumeb Keetmanshoop Otjiwarongo Luderitz Swakopmund Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
56
3.35 NIGER Biotechnology (US $ mln): Niger 1998 - 2008 Year
Niger
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Niger: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
783 1,452 1,536 1,654 1,761 1,854 1,901
0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.07
61.99 12.93 10.12 6.54 4.21 2.49 1.71 100.00
0.37 0.08 0.06 0.04 0.03 0.01 0.01 0.60
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Niamey Zinder Maradi Tahoua Agadez Birni N'Konni Filingue Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
57
3.36 NIGERIA Biotechnology (US $ mln): Nigeria 1998 - 2008 Year
Nigeria
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
7.01% 7.01% 7.01% 7.01% 7.00% 7.01% 7.01% 7.01% 7.01% 7.01% 7.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Nigeria: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
330 354 603 640 777 778 824 839 870 871 876 919 959 978 1,076
0.13 0.13 0.06 0.06 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.04 0.78
17.07 16.09 8.20 7.57 5.37 5.35 4.81 4.60 4.26 4.26 4.18 3.85 3.55 3.36 2.59 4.90 100.00
1.20 1.13 0.57 0.53 0.38 0.38 0.34 0.32 0.30 0.30 0.29 0.27 0.25 0.24 0.18 0.34 7.01
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Lagos Ibadan Ogbomosho Kano Oshogbo Ilorin Abeokuta Port Harcourt Ilesha Zaria Onitsha Kaduna Enugu Aba Benin City Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
58
3.37 REPUBLIC OF CONGO Biotechnology (US $ mln): Republic of Congo 1998 - 2008 Year
Republic of Congo
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Republic of Congo: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,318 1,563 1,939 1,948 1,993 2,023 2,030
0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.02
58.32 29.16 3.72 3.62 2.45 1.57 1.17 100.00
0.11 0.05 0.01 0.01 0.00 0.00 0.00 0.19
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Brazzaville Pointe-Noire Nkayi Loubomo Ngamaba-Mfilou Loandjili Mossendjo Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
59
3.38 REUNION Biotechnology (US $ mln): Reunion 1998 - 2008 Year
Reunion
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.21% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.21% 0.21%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Reunion: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,503 1,650 1,709 1,750 1,796 1,816
0.01 0.00 0.00 0.00 0.00 0.00 0.02
32.61 19.41 15.90 12.94 9.97 9.16 100.00
0.07 0.04 0.03 0.03 0.02 0.02 0.20
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Saint-Denis Saint-Paul Saint-Pierre Le Tampon Saint-Louis Le Port Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
60
3.39 RWANDA Biotechnology (US $ mln): Rwanda 1998 - 2008 Year
Rwanda
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.40% 0.40% 0.39% 0.39% 0.38% 0.39% 0.39% 0.40% 0.40% 0.40% 0.41%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Rwanda: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
917 1,658 1,745 1,793 1,834 1,866
0.03 0.00 0.00 0.00 0.00 0.00 0.04
69.78 9.78 7.11 5.33 4.44 3.56 100.00
0.27 0.04 0.03 0.02 0.02 0.01 0.39
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Kigali Butare Ruhengeri Gisenyi Nyabisindu Cyangugu Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
61
3.40 SAO TOME E PRINCIPE Biotechnology (US $ mln): Sao Tome E Principe 1998 - 2008 Year
Sao Tome E Principe
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Sao Tome E Principe: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,900 2,065
0.00 0.00 0.00
97.22 2.78 100.00
0.01 0.00 0.01
0.00 0.00 0.00
_________________________________________________________________________________________________________
Sao Tome Santo Antonio Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
3.41 SENEGAL Biotechnology (US $ mln): Senegal 1998 - 2008 Year
Senegal
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.00% 0.99% 0.98% 0.97% 0.96% 0.97% 0.98% 0.99% 1.00% 1.01% 1.02%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
62
Senegal: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
524 1,450 1,507 1,565 1,591 1,743
0.08 0.01 0.01 0.01 0.01 0.00 0.11
71.64 8.09 6.84 5.55 5.03 2.85 100.00
0.69 0.08 0.07 0.05 0.05 0.03 0.97
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Dakar Thies Kaolack Zinguinchor Saint-Louis Diourbel Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
3.42 SIERRA LEONE Biotechnology (US $ mln): Sierra Leone 1998 - 2008 Year
Sierra Leone
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Sierra Leone: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,190 1,927 1,998 2,001 2,036 2,037
0.02 0.00 0.00 0.00 0.00 0.00 0.02
88.18 4.88 2.44 2.25 1.13 1.13 100.00
0.14 0.01 0.00 0.00 0.00 0.00 0.16
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Freetown Bo Kenema Makeni Bonthe Port Loko Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
63
3.43 SOMALIA Biotechnology (US $ mln): Somalia 1998 - 2008 Year
Somalia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.25% 0.25% 0.25% 0.26% 0.26% 0.26% 0.25% 0.25% 0.25% 0.25% 0.25%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Somalia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,315 1,623 1,705 1,706 1,787 1,930 1,952 2,046
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03
42.66 17.06 12.80 12.80 8.53 2.99 2.56 0.60 100.00
0.11 0.04 0.03 0.03 0.02 0.01 0.01 0.00 0.26
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Mogadishu Hargeysa Burao Baidoa Kismaayo Berbera Marka Giohar Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
64
3.44 SOUTH AFRICA Biotechnology (US $ mln): South Africa 1998 - 2008 Year
South Africa
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
2 2 2 2 2 2 3 3 3 3 3
21.89% 21.95% 22.00% 22.04% 22.07% 22.04% 22.00% 21.96% 21.91% 21.86% 21.80%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
South Africa: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
96 110 115 267 668 744 768 896 1,019 1,026 1,050 1,208
0.77 0.64 0.61 0.17 0.05 0.04 0.04 0.03 0.02 0.02 0.02 0.02 2.45
31.46 26.26 24.90 6.93 2.21 1.82 1.73 1.27 0.97 0.95 0.88 0.63 100.00
6.93 5.79 5.49 1.53 0.49 0.40 0.38 0.28 0.21 0.21 0.19 0.14 22.04
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Johannesburg Cape Town Pretoria Durban Roodepoort Germiston Boksburg Umlazi Bloemfontein Pietermaritzburg Port Elizabeth East London Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
65
3.45 SUDAN Biotechnology (US $ mln): Sudan 1998 - 2008 Year
Sudan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
2.30% 2.26% 2.22% 2.18% 2.15% 2.17% 2.21% 2.25% 2.28% 2.32% 2.36%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Sudan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
555 589 928 1,093 1,100 1,254 1,266 1,446
0.07 0.06 0.03 0.02 0.02 0.01 0.01 0.01 0.24
29.89 26.85 12.24 8.01 7.90 5.81 5.64 3.67 100.00
0.65 0.58 0.27 0.17 0.17 0.13 0.12 0.08 2.17
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Omdurman Khartoum Port Sudan Wadi Medani Al Obeid Atbara Kassala Kosti Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
66
3.46 SWAZILAND Biotechnology (US $ mln): Swaziland 1998 - 2008 Year
Swaziland
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Swaziland: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,264 1,549 1,716 1,784 1,877 1,910 1,959
0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.03
46.99 21.69 12.05 8.43 4.82 3.61 2.41 100.00
0.12 0.06 0.03 0.02 0.01 0.01 0.01 0.26
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Mbabane Manzini Big Bend Mhlume Nhlangano Pigg's Peak Siteki Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
67
3.47 TANZANIA Biotechnology (US $ mln): Tanzania 1998 - 2008 Year
Tanzania
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.56% 1.54% 1.53% 1.52% 1.51% 1.52% 1.53% 1.54% 1.55% 1.57% 1.58%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Tanzania: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
425 1,256 1,259 1,288 1,416 1,458 1,528 1,572
0.10 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.17
57.47 8.30 8.22 7.70 5.75 5.01 4.11 3.44 100.00
0.87 0.13 0.12 0.12 0.09 0.08 0.06 0.05 1.52
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Dar es Salaam Mwanza Zanzibar Tanga Mbeya Tabora Arusha Dodoma Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
68
3.48 THE GAMBIA Biotechnology (US $ mln): The Gambia 1998 - 2008 Year
The Gambia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
The Gambia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,625 1,820 1,923 1,926 1,996 2,020 2,021 2,052 2,053
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
47.69 20.37 9.26 8.80 4.63 3.24 3.24 1.39 1.39 100.00
0.04 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.09
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Serrekunda Banjul Brikama Bakau Farefenni Gunjur Sukuta Georgetown Basse Santa Su Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
69
3.49 TOGO Biotechnology (US $ mln): Togo 1998 - 2008 Year
Togo
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Togo: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
884 1,659 1,758 1,790 1,832 1,870 1,894 1,902 1,928 1,999
0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05
66.06 8.66 5.78 4.87 3.97 3.07 2.53 2.35 1.81 0.90 100.00
0.29 0.04 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.44
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Lome Sokodé Palimé Atakpamé Bassari Tsévié Anécho Mango Bafilo Tabligbo Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
70
3.50 TUNISIA Biotechnology (US $ mln): Tunisia 1998 - 2008 Year
Tunisia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 1 1 1
3.88% 3.85% 3.82% 3.79% 3.77% 3.79% 3.82% 3.84% 3.87% 3.90% 3.92%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Tunisia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
268 582 950 969 982 983 1,018 1,071 1,138 1,151
0.17 0.07 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.42
40.17 15.61 6.66 6.39 6.19 6.19 5.65 4.85 4.17 4.10 100.00
1.52 0.59 0.25 0.24 0.23 0.23 0.21 0.18 0.16 0.16 3.79
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Tunis Sfax Ariana Bizerte Djerba Gabes Sousse Kairouan La Goulette Gafsa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
71
3.51 UGANDA Biotechnology (US $ mln): Uganda 1998 - 2008 Year
Uganda
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.65% 1.63% 1.61% 1.59% 1.57% 1.59% 1.61% 1.63% 1.65% 1.66% 1.68%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Uganda: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
355 1,238 1,483 1,493 1,553 1,575 1,619 1,620
0.12 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.18
70.72 8.17 4.47 4.31 3.54 3.24 2.77 2.77 100.00
1.12 0.13 0.07 0.07 0.06 0.05 0.04 0.04 1.59
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Kampala Jinja Masaka Mbale Mbarara Entebbe Gulu Tororo Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
72
3.52 WESTERN SAHARA Biotechnology (US $ mln): Western Sahara 1998 - 2008 Year
Western Sahara
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Western Sahara: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
2,015 2,061 2,062
0.00 0.00 0.00 0.00
72.31 13.85 13.85 100.00
0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Laayoune Dakhla Semara Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
73
3.53 ZAMBIA Biotechnology (US $ mln): Zambia 1998 - 2008 Year
Zambia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.52% 0.52%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Zambia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,140 1,424 1,443 1,672 1,673 1,681 1,730 1,825 1,835 1,856
0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06
30.87 16.75 15.72 7.10 7.06 6.88 5.89 3.48 3.34 2.91 100.00
0.16 0.09 0.08 0.04 0.04 0.04 0.03 0.02 0.02 0.01 0.51
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Lusaka Kitwe Ndola Kabwe Mufulira Chingola Luanshya Livingstone Kalulushi Chililabombwe Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
74
3.54 ZIMBABWE Biotechnology (US $ mln): Zimbabwe 1998 - 2008 Year
Zimbabwe
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.38% 1.45% 1.53% 1.61% 1.67% 1.61% 1.54% 1.47% 1.41% 1.34% 1.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Zimbabwe: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
559 740 1,054 1,466 1,506 1,608 1,630 1,667 1,734 1,755 1,756 1,778
0.07 0.05 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.18
40.01 25.21 11.87 4.64 4.11 2.82 2.64 2.29 1.82 1.59 1.59 1.41 100.00
0.64 0.41 0.19 0.07 0.07 0.05 0.04 0.04 0.03 0.03 0.03 0.02 1.61
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Harare Bulawayo Chitungwiza Gweru Mutare Kwekwe Kadoma Hwange Masvingo Chegutu Zvishavane Chinhoyi Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
75
4 ASIA: BIOTECHNOLOGY 4.1
EXECUTIVE SUMMARY Market Potential for Biotechnology in Asia (US $ mln): 2003
Country
Latent Demand US $ mln
% of Asia
31 21 15 5 4 3 3 2 2 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 91
33.93% 22.80% 16.28% 5.74% 4.81% 3.03% 2.86% 2.27% 1.68% 1.50% 1.36% 1.14% 0.83% 0.47% 0.46% 0.25% 0.16% 0.12% 0.09% 0.07% 0.06% 0.04% 0.03% 0.02% 0.00% 0.00% 100.00%
_________________________________________________________________________________________________________
China Japan India South Korea Indonesia Thailand Taiwan Philippines Malaysia Bangladesh Hong Kong Vietnam Singapore Burma Sri Lanka Nepal North Korea Cambodia Papua New Guinea Laos Macau Brunei Mongolia Bhutan Maldives Other Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
76
Market Potential for Biotechnology in Asia (US $ mln): 2003 India South Korea
Japan
Other China
The Market for Biotechnology in Asia: 1998 - 2008 Year
US $ mln
% of Globe
70.23 73.32 76.64 80.21 84.39 90.94 98.39 106.47 115.25 124.78 135.13
0.39 0.37 0.35 0.34 0.32 0.32 0.31 0.31 0.30 0.30 0.29
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
4.2
77
BANGLADESH Biotechnology (US $ mln): Bangladesh 1998 - 2008
Year
Bangladesh
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 2 2 2 2
1.67% 1.63% 1.59% 1.55% 1.51% 1.50% 1.49% 1.48% 1.47% 1.47% 1.46%
0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Bangladesh: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
119 210 284 587 617 735 751 779 793 831 838 907
0.57 0.24 0.16 0.07 0.06 0.05 0.04 0.04 0.04 0.04 0.04 0.03 1.36
41.79 17.31 11.41 4.79 4.49 3.37 3.25 3.06 2.97 2.70 2.63 2.24 100.00
0.63 0.26 0.17 0.07 0.07 0.05 0.05 0.05 0.04 0.04 0.04 0.03 1.50
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Dhaka Chittagong Khulna Narayanganj Rajshahi Mymensingh Comilla Barisal Sylhet Rangpur Jessore Saidpur Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
4.3
78
BHUTAN Biotechnology (US $ mln): Bhutan 1998 - 2008
Year
Bhutan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Bhutan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,676 1,694 1,772 1,809 1,827 1,977 1,978
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
25.32 24.05 16.46 13.92 12.66 3.80 3.80 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Thimphu Taga Dzong Punakha Bumthang Phuntsholing Tongsa Dzong Paro Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
4.4
79
BRUNEI Biotechnology (US $ mln): Brunei 1998 - 2008
Year
Brunei
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.05% 0.05% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Brunei: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,052 1,409 1,485
0.02 0.01 0.01 0.04
54.74 25.26 20.00 100.00
0.02 0.01 0.01 0.04
0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Bandar Seri Begawan Seria Kuala Belait Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
4.5
80
BURMA Biotechnology (US $ mln): Burma 1998 - 2008
Year
Burma
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 1 1 1
0.52% 0.51% 0.50% 0.48% 0.47% 0.47% 0.47% 0.46% 0.46% 0.46% 0.45%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Burma: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
191 637 1,008 1,168 1,188 1,319 1,320 1,326
0.27 0.06 0.02 0.02 0.02 0.01 0.01 0.01 0.43
64.22 13.92 5.75 3.92 3.76 2.82 2.82 2.79 100.00
0.30 0.07 0.03 0.02 0.02 0.01 0.01 0.01 0.47
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Yangon Mandalay Moulmein Pegu Bassein Taunggye Sittwe Monywa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
4.6
81
CAMBODIA Biotechnology (US $ mln): Cambodia 1998 - 2008
Year
Cambodia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.13% 0.13% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.11% 0.11% 0.11%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Cambodia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
477 1,021
0.08 0.02 0.11
77.88 22.12 100.00
0.09 0.03 0.12
0.00 0.00 0.00
_________________________________________________________________________________________________________
Bhnom Penh Kompong Cham Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.7
CHINA Biotechnology (US $ mln): China 1998 - 2008
Year
China
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
19 21 23 26 28 31 34 37 41 45 50
27.28% 28.75% 30.25% 31.80% 33.24% 33.93% 34.50% 35.07% 35.64% 36.21% 36.78%
0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
82
China: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
44 45 48 49 50 55 61 62 63 66 68 70 71 76 93
4.42 3.68 3.12 2.84 2.62 2.26 1.49 1.48 1.47 1.37 1.26 1.20 1.19 1.13 0.78 0.54 30.86
14.32 11.93 10.10 9.21 8.48 7.33 4.84 4.80 4.78 4.43 4.07 3.89 3.85 3.66 2.54 1.76 100.00
4.86 4.05 3.43 3.13 2.88 2.49 1.64 1.63 1.62 1.50 1.38 1.32 1.31 1.24 0.86 0.60 33.93
0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11
_________________________________________________________________________________________________________
Shanghai Beijing Chongqing Guangzhou Chengdu Tianjin Harbin Nanjing Wuhan Jinan Shenyang Changchun Xi'an Dalian Shenzhen Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.8
HONG KONG Biotechnology (US $ mln): Hong Kong 1998 - 2008
Year
Hong Kong
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 2 2 2 2
1.63% 1.56% 1.48% 1.41% 1.35% 1.36% 1.39% 1.41% 1.43% 1.46% 1.48%
0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
83
Hong Kong: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
69
1.24 1.24
100.00 100.00
1.36 1.36
0.00 0.00
_________________________________________________________________________________________________________
Hong Kong Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.9
INDIA Biotechnology (US $ mln): India 1998 - 2008
Year
India
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
13 13 13 13 14 15 16 17 19 20 22
18.33% 17.83% 17.33% 16.82% 16.37% 16.28% 16.25% 16.22% 16.19% 16.14% 16.10%
0.07% 0.07% 0.06% 0.06% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
84
India: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
53 59 72 75 78 81 82 88 89 108 109 134 142 163 169
2.55 1.75 1.18 1.14 1.02 0.92 0.92 0.84 0.83 0.65 0.65 0.47 0.43 0.37 0.34 0.73 14.81
17.25 11.84 7.99 7.68 6.89 6.23 6.22 5.65 5.64 4.41 4.38 3.15 2.93 2.50 2.31 4.94 100.00
2.81 1.93 1.30 1.25 1.12 1.01 1.01 0.92 0.92 0.72 0.71 0.51 0.48 0.41 0.38 0.80 16.28
0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05
_________________________________________________________________________________________________________
Maharashtra State Uttar Pradesh State West Bengal State Andhra Pradesh State Tamil Nadu State Gujarat State Madhya Pradesh State Karnataka State Bihar State Rajasthan State Punjab State Haryana State Kerala State Orissa State Union Territories Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.10 INDONESIA Biotechnology (US $ mln): Indonesia 1998 - 2008 Year
Indonesia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
4 4 4 4 4 4 5 5 5 6 6
5.32% 5.21% 5.09% 4.97% 4.86% 4.81% 4.78% 4.74% 4.70% 4.67% 4.63%
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
85
Indonesia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
92 105 106 139 206 235 281 293 340 414 488 503 515 535 562
0.79 0.70 0.67 0.45 0.25 0.20 0.16 0.15 0.13 0.10 0.08 0.08 0.08 0.08 0.07 0.39 4.38
18.11 15.94 15.31 10.34 5.62 4.58 3.58 3.46 2.97 2.35 1.86 1.83 1.78 1.72 1.63 8.91 100.00
0.87 0.77 0.74 0.50 0.27 0.22 0.17 0.17 0.14 0.11 0.09 0.09 0.09 0.08 0.08 0.43 4.81
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
_________________________________________________________________________________________________________
Jawa Barat DKI jakarta Jawa Timur Jawa Tengah Sumatra Utara Riau Kalimentan Timur Sumatra Selatan Daerah Istimerwa Aceh Sulawesi Selatan Sumatra Barat Lampung Kalimantan Barat Bali Irian Jaya Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.11 JAPAN Biotechnology (US $ mln): Japan 1998 - 2008 Year
Japan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
17 17 18 19 20 21 22 23 24 26 27
23.83% 23.75% 23.65% 23.51% 23.30% 22.80% 22.26% 21.73% 21.21% 20.70% 20.20%
0.09% 0.09% 0.08% 0.08% 0.08% 0.07% 0.07% 0.07% 0.06% 0.06% 0.06%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
86
Japan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
46 64 91 97 122 132 136 143 151 154 176 177 195 202 215
3.47 1.41 0.80 0.77 0.55 0.50 0.46 0.43 0.41 0.39 0.33 0.33 0.27 0.26 0.22 10.14 20.73
16.75 6.79 3.88 3.70 2.66 2.41 2.20 2.09 1.97 1.88 1.59 1.58 1.29 1.23 1.08 48.89 100.00
3.82 1.55 0.89 0.84 0.61 0.55 0.50 0.48 0.45 0.43 0.36 0.36 0.30 0.28 0.25 11.15 22.80
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.07
_________________________________________________________________________________________________________
Tokyo (23-wards) Yokohama Nagoya Osaka Sapporo Kawasaki Kyoto Kobe Fukuoka Hiroshima Chiba Sendai Kitakyushu Sakai Sagamihara Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.12 LAOS Biotechnology (US $ mln): Laos 1998 - 2008 Year
Laos
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.06% 0.06% 0.06% 0.06%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
87
Laos: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
780 1,579 1,611 1,622 1,865 1,873
0.04 0.01 0.00 0.00 0.00 0.00 0.06
69.30 9.38 8.27 8.09 2.57 2.39 100.00
0.05 0.01 0.01 0.01 0.00 0.00 0.07
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Vientiane Savannakhet Pakse Luang Prabang Sayaboury Khammouane Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.13 MACAU Biotechnology (US $ mln): Macau 1998 - 2008 Year
Macau
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.05% 0.05% 0.05% 0.05%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Macau: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
710 1,791 1,960
0.05 0.00 0.00 0.05
94.12 4.52 1.36 100.00
0.05 0.00 0.00 0.06
0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Macau Taipa Coloane Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
88
4.14 MALAYSIA Biotechnology (US $ mln): Malaysia 1998 - 2008 Year
Malaysia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 2 2 2 2 2 2
1.96% 1.89% 1.81% 1.73% 1.67% 1.68% 1.69% 1.71% 1.73% 1.74% 1.76%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Malaysia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
172 392 429 463 541 556 560 577 583 592 593 616 645 672 675
0.34 0.11 0.10 0.09 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.05 0.05 0.18 1.52
22.08 7.38 6.34 5.71 4.92 4.72 4.70 4.41 4.31 4.24 4.23 4.02 3.83 3.53 3.52 12.06 100.00
0.37 0.12 0.11 0.10 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.20 1.68
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Kuala Lumpur Ipoh Johor Baharu Melaka Petaling Jaya Tawai Kelang Kuala Terengganu Sandakan Kota Baharu George Town Kota Kinabalu Kuantan Taiping Seremban Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
89
4.15 MALDIVES Biotechnology (US $ mln): Maldives 1998 - 2008 Year
Maldives
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Maldives: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,671
0.00 0.00
100.00 100.00
0.00 0.00
0.00 0.00
_________________________________________________________________________________________________________
Male Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.16 MONGOLIA Biotechnology (US $ mln): Mongolia 1998 - 2008 Year
Mongolia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
90
Mongolia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,031 1,732 1,846 1,920 1,973 1,974 1,980
0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.03
74.25 10.84 5.83 3.12 2.03 2.03 1.90 100.00
0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.03
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Ulaanbaatar Darhan Erdenedalay Choybalsan Ulaangom Nalayh Uliastay Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.17 NEPAL Biotechnology (US $ mln): Nepal 1998 - 2008 Year
Nepal
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.27% 0.26% 0.26% 0.25% 0.25% 0.25% 0.24% 0.24% 0.24% 0.23% 0.23%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Nepal: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
638 814 825 869 1,022 1,074 1,316
0.06 0.04 0.04 0.03 0.02 0.02 0.01 0.22
26.43 17.10 16.65 14.85 10.57 9.00 5.40 100.00
0.07 0.04 0.04 0.04 0.03 0.02 0.01 0.25
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Kathmandu Sallyan Pyuthan Jumla Biratnagar Lalitpur Bhaktapur Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
91
4.18 NORTH KOREA Biotechnology (US $ mln): North Korea 1998 - 2008 Year
North Korea
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.15% 0.16% 0.16% 0.16% 0.16% 0.16% 0.15% 0.14% 0.14% 0.13% 0.12%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
North Korea: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
653 1,183 1,228 1,370 1,454 1,501 1,502 1,522 1,564 1,640 1,763
0.06 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.14
39.81 11.37 10.42 7.54 6.03 5.28 5.22 4.90 4.24 3.21 1.96 100.00
0.06 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.16
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Pyongyang Chongjin Nampo Sinuiju Hungnam Wonsan Kaesong Hamhung Kimchaek Haeju Sariwon Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
92
4.19 PAPUA NEW GUINEA Biotechnology (US $ mln): Papua New Guinea 1998 - 2008 Year
Papua New Guinea
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.10% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.08% 0.08% 0.08%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Papua New Guinea: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
828 1,089 1,559 1,580 1,592 1,677 1,736
0.04 0.02 0.01 0.01 0.01 0.00 0.00 0.08
45.92 24.17 7.55 6.95 6.65 4.83 3.93 100.00
0.04 0.02 0.01 0.01 0.01 0.00 0.00 0.09
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Port Moresby Lae Madang Wewak Goroka Rabaul Mount Hagen Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
93
4.20 PHILIPPINES Biotechnology (US $ mln): Philippines 1998 - 2008 Year
Philippines
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
2 2 2 2 2 2 2 2 3 3 3
2.46% 2.42% 2.38% 2.34% 2.30% 2.27% 2.24% 2.21% 2.18% 2.15% 2.12%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Philippines: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
57 767 1,013 1,147 1,181 1,344 1,351 1,383 1,406 1,411 1,419 1,451 1,453 1,484 1,486
1.82 0.04 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.04 2.06
88.46 2.05 1.18 0.84 0.79 0.55 0.54 0.51 0.49 0.48 0.47 0.42 0.42 0.38 0.38 2.06 100.00
2.01 0.05 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.05 2.27
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Manila Quezon City Davao Cebu Caloocan Makati Zamboanga Cagayan de Oro Pasig Pasay Las Pinas Bacolod Valenzuela Marikina Paranaque Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
94
4.21 SEYCHELLES Biotechnology (US $ mln): Seychelles 1998 - 2008 Year
Seychelles
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Seychelles: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,759 1,995 2,009 2,010
0.00 0.00 0.00 0.00 0.00
69.70 12.12 9.09 9.09 100.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Victoria Anse Boileau Cascade Anse Royale Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
95
4.22 SINGAPORE Biotechnology (US $ mln): Singapore 1998 - 2008 Year
Singapore
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
0.99% 0.95% 0.90% 0.86% 0.82% 0.83% 0.84% 0.86% 0.87% 0.89% 0.90%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Singapore: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
99
0.75 0.75
100.00 100.00
0.83 0.83
0.00 0.00
_________________________________________________________________________________________________________
Singapore Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.23 SOUTH KOREA Biotechnology (US $ mln): South Korea 1998 - 2008 Year
South Korea
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
5 5 5 5 5 5 6 6 7 8 8
6.77% 6.49% 6.21% 5.93% 5.71% 5.74% 5.81% 5.88% 5.95% 6.01% 6.08%
0.03% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
96
South Korea: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
54 111 138 164 219 220 232 246 358 410 439 677
2.55 0.64 0.45 0.37 0.22 0.22 0.21 0.19 0.12 0.10 0.09 0.05 5.22
48.85 12.29 8.68 7.05 4.16 4.16 3.99 3.62 2.37 1.99 1.81 1.03 100.00
2.80 0.71 0.50 0.40 0.24 0.24 0.23 0.21 0.14 0.11 0.10 0.06 5.74
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
_________________________________________________________________________________________________________
Seoul Pusan Inchon Taegu Taejon Kwangju Ulsan Suwon Masan Chonju Cheju Mokpo Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.24 SRI LANKA Biotechnology (US $ mln): Sri Lanka 1998 - 2008 Year
Sri Lanka
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 1 1 1
0.52% 0.51% 0.49% 0.48% 0.47% 0.46% 0.46% 0.46% 0.46% 0.46% 0.45%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
97
Sri Lanka: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
243 676 794 806 835 905 1,155 1,307
0.19 0.05 0.04 0.04 0.04 0.03 0.02 0.01 0.42
45.56 12.74 9.54 9.21 8.67 7.27 4.07 2.94 100.00
0.21 0.06 0.04 0.04 0.04 0.03 0.02 0.01 0.46
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Colombo Dehiwala Jaffna Moratuwa Kandy Galle Negombo Trincomalee Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.25 TAIWAN Biotechnology (US $ mln): Taiwan 1998 - 2008 Year
Taiwan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
2 2 2 2 2 3 3 3 3 4 4
3.24% 3.14% 3.05% 2.96% 2.87% 2.86% 2.86% 2.86% 2.86% 2.85% 2.85%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
98
Taiwan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
94 178 217 327 406 517 523 532 557 629 647 670 689 703 727
0.78 0.33 0.22 0.13 0.11 0.08 0.08 0.08 0.07 0.06 0.06 0.05 0.05 0.05 0.05 0.41 2.60
29.96 12.60 8.52 5.14 4.07 2.99 2.97 2.92 2.77 2.30 2.23 2.07 2.01 1.92 1.79 15.72 100.00
0.86 0.36 0.24 0.15 0.12 0.09 0.08 0.08 0.08 0.07 0.06 0.06 0.06 0.06 0.05 0.45 2.86
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Taipei Kaohsuing Taichung Tainan Panchiao Hsinchu Chungho Sanchung Keelung Chungli Chiayi Taoyuan Fengshan Hsintien Yungho Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.26 THAILAND Biotechnology (US $ mln): Thailand 1998 - 2008 Year
Thailand
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
2 2 2 3 3 3 3 3 3 4 4
3.32% 3.26% 3.19% 3.13% 3.07% 3.03% 3.00% 2.97% 2.94% 2.91% 2.87%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
99
Thailand: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
52 435 933 1,150 1,167 1,217 1,361 1,629 1,966
2.57 0.10 0.03 0.02 0.02 0.02 0.01 0.00 0.00 2.76
93.11 3.46 1.06 0.63 0.61 0.55 0.40 0.17 0.02 100.00
2.82 0.10 0.03 0.02 0.02 0.02 0.01 0.01 0.00 3.03
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Bangkok Chon Buri Songkhla Nakhon Ratchasima Chiang Mai Khon Kaen Nakhon Si Thammarat Phitsanulok Hat Yai Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
4.27 VIETNAM Biotechnology (US $ mln): Vietnam 1998 - 2008 Year
Vietnam
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 2
1.27% 1.24% 1.21% 1.18% 1.15% 1.14% 1.14% 1.13% 1.13% 1.12% 1.11%
0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
100
Vietnam: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
180 189 248 490 493 604 1,065
0.33 0.28 0.19 0.08 0.08 0.06 0.02 1.04
31.46 26.70 18.05 7.83 7.81 6.15 2.00 100.00
0.36 0.30 0.21 0.09 0.09 0.07 0.02 1.14
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Ho Chi Minh Can Tho Hanoi Thai Nguyen Da Nang Hue Pleyku Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
101
5 EUROPE: BIOTECHNOLOGY 5.1
EXECUTIVE SUMMARY Market Potential for Biotechnology in Europe (US $ mln): 2003
Country
Latent Demand US $ mln
% of Europe
13 10 9 8 5 4 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 2 72
17.95% 13.43% 12.61% 11.78% 6.71% 5.27% 3.62% 3.06% 2.42% 1.92% 1.88% 1.84% 1.78% 1.69% 1.47% 1.26% 1.22% 1.22% 1.15% 1.11% 1.07% 0.82% 0.78% 0.73% 0.51% 2.68% 100.00%
_________________________________________________________________________________________________________
Germany France United Kingdom Italy Spain Russia Netherlands Poland Belgium Switzerland Austria Sweden Ukraine Greece Portugal Denmark Czech Republic Romania Norway Finland Hungary Kazakhstan Ireland Belarus Slovakia Other Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
102
Market Potential for Biotechnology in Europe (US $ mln): 2003 United Kingdom
Italy
France
Other Germany
The Market for Biotechnology in Europe: 1998 - 2008 Year
US $ mln
% of Globe
59.98 61.65 63.38 65.16 67.32 71.58 76.46 81.68 87.26 93.22 99.59
0.34 0.31 0.29 0.27 0.26 0.25 0.24 0.24 0.23 0.22 0.22
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
5.2
103
ALBANIA Biotechnology (US $ mln): Albania 1998 - 2008
Year
Albania
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.11% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.11% 0.11%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Albania: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,028 1,478 1,480 1,488 1,525 1,548 1,660 1,668 1,765
0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.07
32.42 11.33 11.19 10.90 9.76 8.90 5.88 5.74 3.87 100.00
0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.10
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Tirane Durres Elbasan Shkoder Vlore Korce Berat Fier Lushnje Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
5.3
104
ANDORRA Biotechnology (US $ mln): Andorra 1998 - 2008
Year
Andorra
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Andorra: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,632 1,739
0.00 0.00 0.01
60.00 40.00 100.00
0.01 0.00 0.01
0.00 0.00 0.00
_________________________________________________________________________________________________________
Andorra la Vella Les Escaldes Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.4
AUSTRIA Biotechnology (US $ mln): Austria 1998 - 2008
Year
Austria
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 2 2 2 2
1.87% 1.87% 1.88% 1.88% 1.89% 1.88% 1.88% 1.87% 1.87% 1.86% 1.86%
0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
105
Austria: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
90 346 407 547 615 734 951 966 975 1,077 1,227 1,547
0.81 0.13 0.11 0.07 0.06 0.05 0.03 0.03 0.03 0.02 0.01 0.01 1.35
60.06 9.53 7.85 5.45 4.59 3.41 2.08 2.00 1.96 1.49 1.10 0.47 100.00
1.13 0.18 0.15 0.10 0.09 0.06 0.04 0.04 0.04 0.03 0.02 0.01 1.88
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Vienna Graz Linz Salzburg Innsbruck Klagenfurt Villach Wels Sankt Poelten Steyr Bregenz Eisenstadt Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.5
BELARUS Biotechnology (US $ mln): Belarus 1998 - 2008
Year
Belarus
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 1 1 1 1 1 1
0.74% 0.74% 0.74% 0.73% 0.73% 0.73% 0.74% 0.74% 0.74% 0.74% 0.74%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
106
Belarus: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
236 612 743 754 861 881 953 1,080 1,123 1,203 1,224 1,299
0.20 0.06 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.53
37.91 11.93 8.49 8.35 6.44 6.15 5.32 3.79 3.44 2.93 2.84 2.41 100.00
0.28 0.09 0.06 0.06 0.05 0.05 0.04 0.03 0.03 0.02 0.02 0.02 0.73
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Minsk Gomel Mogilyov Vitebsk Grodno Brest Bobruysk Baranovichi Borisov Orsha Pinsk Mozyr Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.6
BELGIUM Biotechnology (US $ mln): Belgium 1998 - 2008
Year
Belgium
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 2 2 2 2 2 2 2 2 2
2.43% 2.43% 2.42% 2.42% 2.41% 2.42% 2.42% 2.43% 2.43% 2.44% 2.44%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
107
Belgium: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
116 184 307 338 356 549 599 658 691 716 718 719 769
0.60 0.30 0.14 0.13 0.12 0.07 0.06 0.06 0.05 0.05 0.05 0.05 0.04 1.73
34.89 17.12 8.38 7.52 7.19 4.24 3.71 3.24 3.02 2.77 2.73 2.73 2.45 100.00
0.84 0.41 0.20 0.18 0.17 0.10 0.09 0.08 0.07 0.07 0.07 0.07 0.06 2.42
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Brussels Antwerp Ghent Charleroi Liege Bruges Namur Mons Leuven Aalst Mechelen Kortrijk Oostende Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.7
BOSNIA AND HERZEGOVINA Biotechnology (US $ mln): Bosnia and Herzegovina 1998 - 2008
Year
Bosnia and Herzegovina
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.07% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.07% 0.07% 0.07%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
108
Bosnia and Herzegovina: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,148 1,544 1,626 1,655 1,662 1,697 1,725
0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.04
39.33 14.57 10.84 9.80 9.44 8.37 7.63 100.00
0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.06
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Sarajevo Banja Luca Zenica Tuzla Mostar Prijedor Doboj Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.8
BULGARIA Biotechnology (US $ mln): Bulgaria 1998 - 2008
Year
Bulgaria
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.46% 0.46% 0.45% 0.45% 0.45% 0.45% 0.45% 0.45% 0.46% 0.46% 0.46%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
109
Bulgaria: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
353 797 859 1,043 1,057 1,149 1,225 1,308 1,328 1,331 1,368
0.13 0.04 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.32
39.05 12.35 10.58 6.85 6.57 5.40 4.64 3.84 3.70 3.67 3.36 100.00
0.18 0.06 0.05 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.45
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Sofia Plovdiv Varna Burgas Ruse Stara Zagora Pleven Tolbukhin Sliven Shumen Pernik Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.9
CROATIA Biotechnology (US $ mln): Croatia 1998 - 2008
Year
Croatia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
110
Croatia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
443 1,199 1,239 1,300 1,427 1,457 1,543 1,597
0.09 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.17
56.52 9.38 8.71 7.65 5.58 5.10 3.90 3.17 100.00
0.13 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.23
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Zagreb Rijeka Split Osijek Zadar Slavonski Brod Vukovar Dubrovnik Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.10 CYPRUS Biotechnology (US $ mln): Cyprus 1998 - 2008 Year
Cyprus
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Cyprus: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
947 1,072 1,441 1,526
0.03 0.02 0.01 0.01 0.06
43.83 31.50 13.91 10.76 100.00
0.04 0.03 0.01 0.01 0.09
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Nicosia Limassol Larnaca Famagusta Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
111
5.11 DENMARK Biotechnology (US $ mln): Denmark 1998 - 2008 Year
Denmark
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
1.24% 1.25% 1.26% 1.26% 1.26% 1.26% 1.26% 1.25% 1.25% 1.24% 1.24%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Denmark: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
131 432 591 650 915 1,032 1,055 1,056 1,061 1,070 1,176 1,226 1,250
0.50 0.10 0.06 0.06 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.90
55.68 10.63 7.17 6.38 3.34 2.51 2.35 2.35 2.31 2.27 1.81 1.65 1.57 100.00
0.70 0.13 0.09 0.08 0.04 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 1.26
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Copenhagen Aarhus Odense Aalborg Esbjerg Randers Helsingor Kolding Herning Horsens Vejle Roskilde Naestved Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
112
5.12 ESTONIA Biotechnology (US $ mln): Estonia 1998 - 2008 Year
Estonia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.15% 0.15%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Estonia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
655 1,278 1,421 1,439 1,550 1,785 1,792
0.06 0.01 0.01 0.01 0.01 0.00 0.00 0.10
56.71 13.41 9.65 9.06 6.35 2.47 2.35 100.00
0.08 0.02 0.01 0.01 0.01 0.00 0.00 0.14
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Tallinn Tartu Narva Kohtla-Järve Pärnu Sillamäe Rakvere Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
113
5.13 FINLAND Biotechnology (US $ mln): Finland 1998 - 2008 Year
Finland
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
1.14% 1.13% 1.12% 1.11% 1.10% 1.11% 1.12% 1.13% 1.14% 1.15% 1.16%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Finland: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
208 475 484 508 545 711 733 803 807 880 930
0.24 0.08 0.08 0.08 0.07 0.05 0.05 0.04 0.04 0.03 0.03 0.79
30.33 10.54 10.36 9.99 9.31 6.10 5.80 4.93 4.87 4.07 3.70 100.00
0.34 0.12 0.11 0.11 0.10 0.07 0.06 0.05 0.05 0.05 0.04 1.11
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Helsinki Tampere Espoo Turku Vantaa Oulu Lahti Pori Kuopio Jyvaskyla Kotka Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
114
5.14 FRANCE Biotechnology (US $ mln): France 1998 - 2008 Year
France
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
8 8 8 9 9 10 10 11 12 12 13
13.31% 13.35% 13.39% 13.43% 13.45% 13.43% 13.40% 13.36% 13.33% 13.29% 13.25%
0.04% 0.04% 0.04% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
France: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
43 127 128 153 295 344 345 400 424 436 448 479 480 505 516
6.76 0.54 0.54 0.39 0.15 0.13 0.13 0.11 0.10 0.09 0.09 0.08 0.08 0.08 0.08 0.26 9.61
70.30 5.63 5.57 4.05 1.56 1.34 1.34 1.14 1.01 0.99 0.94 0.87 0.87 0.83 0.81 2.75 100.00
9.44 0.76 0.75 0.54 0.21 0.18 0.18 0.15 0.14 0.13 0.13 0.12 0.12 0.11 0.11 0.37 13.43
0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03
_________________________________________________________________________________________________________
Paris Marseille Lyon Lille Toulouse Nice Strasbourg Nantes Rennes Bordeaux Saint-Etienne Reims Le Havre Toulon Grenoble Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
115
5.15 GEORGIA Biotechnology (US $ mln): Georgia 1998 - 2008 Year
Georgia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.20% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.20% 0.20%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Georgia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
442 1,139 1,329 1,402 1,437 1,689 1,783 1,829
0.09 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.15
62.35 11.63 7.87 6.73 5.99 2.52 1.63 1.29 100.00
0.13 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.21
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
T'Bilisi Kutaisi Rustavi Batumi Sukhumi Poti Tskhinvali Chiatura Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
116
5.16 GERMANY Biotechnology (US $ mln): Germany 1998 - 2008 Year
Germany
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
11 11 11 12 12 13 14 15 16 17 18
17.76% 17.82% 17.88% 17.94% 17.99% 17.95% 17.89% 17.84% 17.78% 17.73% 17.67%
0.06% 0.06% 0.05% 0.05% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Germany: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
51 103 140 144 145 147 152 430 514
2.61 0.73 0.45 0.43 0.43 0.41 0.40 0.10 0.08 5.64
20.32 5.66 3.51 3.36 3.34 3.23 3.13 0.75 0.61 43.91
3.65 1.02 0.63 0.60 0.60 0.58 0.56 0.13 0.11 7.88
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
_________________________________________________________________________________________________________
Berlin Cologne Dresden Dusseldorf Dortmund Bremen Duisburg Cottbus Dessau Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
117
5.17 GREECE Biotechnology (US $ mln): Greece 1998 - 2008 Year
Greece
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 2 2
1.70% 1.70% 1.69% 1.69% 1.69% 1.69% 1.69% 1.70% 1.70% 1.70% 1.70%
0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Greece: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
129 209 376 476 619 623 776 865 958 964
0.52 0.24 0.12 0.08 0.06 0.06 0.04 0.03 0.03 0.03 1.21
43.07 19.74 9.58 6.90 5.01 4.96 3.45 2.77 2.28 2.24 100.00
0.73 0.33 0.16 0.12 0.08 0.08 0.06 0.05 0.04 0.04 1.69
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Athens Thessaloniki Piraeus Patras Larissa Iraklion Volos Kavalla Canea Serrai Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
118
5.18 HUNGARY Biotechnology (US $ mln): Hungary 1998 - 2008 Year
Hungary
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
1.10% 1.09% 1.08% 1.07% 1.06% 1.07% 1.08% 1.09% 1.10% 1.11% 1.12%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Hungary: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
137 717 742 790 800 942 990 1,007 1,030 1,107 1,143
0.46 0.05 0.04 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.76
59.51 6.19 5.85 5.32 5.15 3.71 3.35 3.21 2.98 2.45 2.28 100.00
0.64 0.07 0.06 0.06 0.06 0.04 0.04 0.03 0.03 0.03 0.02 1.07
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Budapest Debrecen Miskolc Szeged Pécs Györ Nyiregyha Szekesfehérvar Kecskemét Szombathely Szolnok Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
119
5.19 ICELAND Biotechnology (US $ mln): Iceland 1998 - 2008 Year
Iceland
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Iceland: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
972 1,661 1,679 1,680 1,828 1,880 1,881 1,933 1,934 1,984
0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05
58.54 9.15 8.54 8.54 4.27 3.05 3.05 1.83 1.83 1.22 100.00
0.04 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.06
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Reykjavik Kopavogur Akureyri Hafnarfjordhur Keflavik Akranes Vestmannaeyjar Isafjorour Husavik Neskaupstaour Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
120
5.20 IRELAND Biotechnology (US $ mln): Ireland 1998 - 2008 Year
Ireland
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
0.86% 0.84% 0.81% 0.79% 0.77% 0.78% 0.81% 0.83% 0.86% 0.88% 0.91%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Ireland: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
150 519 852 1,059 1,116
0.41 0.08 0.03 0.02 0.02 0.56
73.10 13.81 6.11 3.73 3.25 100.00
0.57 0.11 0.05 0.03 0.03 0.78
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Dublin Cork Limerick Galway Waterford Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
121
5.21 ITALY Biotechnology (US $ mln): Italy 1998 - 2008 Year
Italy
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
7 7 7 8 8 8 9 10 10 11 11
11.61% 11.67% 11.72% 11.78% 11.82% 11.78% 11.73% 11.68% 11.63% 11.57% 11.52%
0.04% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Italy: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
56 77 83 95 121 123 181 182 187 192 205 233 239 249 257
2.14 1.12 0.91 0.78 0.55 0.55 0.32 0.32 0.28 0.27 0.25 0.21 0.20 0.19 0.18 0.17 8.43
25.35 13.31 10.81 9.22 6.56 6.50 3.84 3.79 3.35 3.23 2.95 2.44 2.33 2.20 2.13 2.00 100.00
2.99 1.57 1.27 1.09 0.77 0.77 0.45 0.45 0.39 0.38 0.35 0.29 0.27 0.26 0.25 0.24 11.78
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03
_________________________________________________________________________________________________________
Rome Milan Naples Turin Palermo Genoa Bologna Florence Catania Bari Venice Messina Verona Taranto Trieste Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
122
5.22 KAZAKHSTAN Biotechnology (US $ mln): Kazakhstan 1998 - 2008 Year
Kazakhstan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
0.91% 0.88% 0.85% 0.82% 0.80% 0.82% 0.85% 0.88% 0.90% 0.93% 0.96%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Kazakhstan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
374 606 791 849 856 868 890 938 977 1,000 1,027 1,044 1,066 1,174 1,192
0.12 0.06 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.06 0.59
19.81 10.78 6.90 5.86 5.81 5.69 5.39 4.86 4.44 4.23 3.93 3.72 3.51 2.79 2.69 9.57 100.00
0.16 0.09 0.06 0.05 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.08 0.82
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Almaty Karaganda Chimkent Semipalatinsk Pavlodar Ust-Kamenogorsk Dzhambul Tselinograd Aktyubinsk Petropavlovsk Kustanay Temirtau Uralsk Shevchenko Kzyl-Orda Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
123
5.23 LATVIA Biotechnology (US $ mln): Latvia 1998 - 2008 Year
Latvia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.17% 0.17% 0.16% 0.16% 0.16% 0.16% 0.16% 0.17% 0.17% 0.17% 0.17%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Latvia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
528 1,372 1,420 1,552 1,585 1,663 1,712
0.08 0.01 0.01 0.01 0.01 0.00 0.00 0.12
65.78 9.18 8.25 5.38 4.73 3.59 3.08 100.00
0.11 0.01 0.01 0.01 0.01 0.01 0.01 0.16
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Riga Daugavpils Liepaja Jelgava Jurmala Ventspils Rezekne Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
124
5.24 LIECHTENSTEIN Biotechnology (US $ mln): Liechtenstein 1998 - 2008 Year
Liechtenstein
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Liechtenstein: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,918 1,919 1,943 1,981 1,982 1,983 2,005
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20.00 20.00 16.00 12.00 12.00 12.00 8.00 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Schaan Vaduz Balzers Mauren Eschen Triesen Triesenberg Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
125
5.25 LITHUANIA Biotechnology (US $ mln): Lithuania 1998 - 2008 Year
Lithuania
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.24% 0.24% 0.24% 0.24% 0.25% 0.24% 0.24% 0.24% 0.24% 0.24% 0.24%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Lithuania: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
553 713 1,024 1,169 1,233
0.07 0.05 0.02 0.02 0.01 0.18
41.37 27.56 13.24 9.48 8.34 100.00
0.10 0.07 0.03 0.02 0.02 0.24
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Vilnius Kaunas Klaipeda Siauliai Panevezys Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
126
5.26 LUXEMBOURG Biotechnology (US $ mln): Luxembourg 1998 - 2008 Year
Luxembourg
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.16% 0.16%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Luxembourg: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
681 1,171 1,355 1,417 1,469 1,470
0.05 0.02 0.01 0.01 0.01 0.01 0.11
49.68 15.48 10.32 9.03 7.74 7.74 100.00
0.07 0.02 0.02 0.01 0.01 0.01 0.15
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Luxembourg Esch Differdange Dudelange Remich Petange Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
127
5.27 MALTA Biotechnology (US $ mln): Malta 1998 - 2008 Year
Malta
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Malta: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,352 1,377 1,487 1,610 1,764
0.01 0.01 0.01 0.01 0.00 0.04
29.85 28.36 20.90 13.43 7.46 100.00
0.02 0.01 0.01 0.01 0.00 0.05
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Birkirkara Qormi Sliema Valletta Victoria Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
128
5.28 MOLDOVA Biotechnology (US $ mln): Moldova 1998 - 2008 Year
Moldova
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.09% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.09% 0.09%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Moldova: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
763 1,332 1,396 1,463
0.04 0.01 0.01 0.01 0.07
58.54 16.02 14.00 11.44 100.00
0.06 0.02 0.01 0.01 0.10
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Chisinau Tiraspol Beltsy Bendery Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
129
5.29 MONACO Biotechnology (US $ mln): Monaco 1998 - 2008 Year
Monaco
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Monaco: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,615 1,946
0.00 0.00 0.01
86.67 13.33 100.00
0.01 0.00 0.01
0.00 0.00 0.00
_________________________________________________________________________________________________________
Monte Carlo Monaco Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.30 NETHERLANDS Biotechnology (US $ mln): Netherlands 1998 - 2008 Year
Netherlands
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
2 2 2 2 2 3 3 3 3 3 4
3.64% 3.63% 3.62% 3.62% 3.61% 3.62% 3.62% 3.63% 3.64% 3.64% 3.65%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
130
Netherlands: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
114 141 155 193 240 259 288 385 481 594 611 872
0.61 0.44 0.39 0.27 0.19 0.17 0.15 0.12 0.08 0.06 0.06 0.03 2.59
23.59 17.08 14.93 10.37 7.50 6.75 5.94 4.44 3.20 2.49 2.42 1.27 100.00
0.85 0.62 0.54 0.38 0.27 0.24 0.21 0.16 0.12 0.09 0.09 0.05 3.62
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Rotterdam Amsterdam - Haarlem Eindhoven - Tilberg Gelderland Utrecht Limburg Overijssel Groningen Friesland Zeeland Drenthe Flevoland Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.31 NORWAY Biotechnology (US $ mln): Norway 1998 - 2008 Year
Norway
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
1.13% 1.14% 1.14% 1.15% 1.15% 1.15% 1.14% 1.14% 1.13% 1.13% 1.12%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
131
Norway: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
175 291 420 566 737 822 842 981 995
0.33 0.15 0.10 0.07 0.05 0.04 0.04 0.03 0.03 0.82
40.14 18.57 12.06 8.54 5.55 4.58 4.31 3.17 3.08 100.00
0.46 0.21 0.14 0.10 0.06 0.05 0.05 0.04 0.04 1.15
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Oslo Bergen Trondheim Stavanger Kristiansand Drammen Tromso Alesund Bodo Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.32 POLAND Biotechnology (US $ mln): Poland 1998 - 2008 Year
Poland
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
2 2 2 2 2 2 2 3 3 3 3
3.12% 3.10% 3.08% 3.06% 3.05% 3.06% 3.08% 3.10% 3.11% 3.13% 3.14%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
132
Poland: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
124 188 207 231 242 289 339 360 366 402 470
0.55 0.28 0.24 0.21 0.19 0.15 0.13 0.12 0.12 0.11 0.09 2.19
24.99 12.64 11.14 9.57 8.76 7.01 5.92 5.58 5.52 4.98 3.89 100.00
0.77 0.39 0.34 0.29 0.27 0.21 0.18 0.17 0.17 0.15 0.12 3.06
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Warsaw Lodz Krakow Wroclaw Poznan Gdansk Szczecin Bydgoszcz Katowice Lublin Sosnowiec Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.33 PORTUGAL Biotechnology (US $ mln): Portugal 1998 - 2008 Year
Portugal
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
1.45% 1.46% 1.46% 1.47% 1.48% 1.47% 1.47% 1.46% 1.45% 1.45% 1.44%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
133
Portugal: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
130 221 628 709 724 801 808 886 960 971
0.52 0.22 0.06 0.05 0.05 0.04 0.04 0.03 0.03 0.03 1.05
49.14 20.54 5.68 4.62 4.44 3.73 3.67 3.02 2.61 2.55 100.00
0.72 0.30 0.08 0.07 0.07 0.05 0.05 0.04 0.04 0.04 1.47
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Lisbon Oporto Amadora Setubal Coimbra Braga Vila Nova de Gaia Barreiro Funchal Almada Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.34 ROMANIA Biotechnology (US $ mln): Romania 1998 - 2008 Year
Romania
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
1.20% 1.20% 1.21% 1.22% 1.23% 1.22% 1.22% 1.21% 1.20% 1.19% 1.18%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
134
Romania: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
166 609 641 644 656 662 683 701 766 771 812
0.36 0.06 0.06 0.06 0.06 0.06 0.05 0.05 0.04 0.04 0.04 0.88
40.80 7.20 6.72 6.66 6.42 6.36 6.05 5.76 4.84 4.82 4.39 100.00
0.50 0.09 0.08 0.08 0.08 0.08 0.07 0.07 0.06 0.06 0.05 1.22
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Bucharest Brasov Constanta Timisoara Iasi Cluj-Napoca Galati Craiova Braila Ploiesti Oradea Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.35 RUSSIA Biotechnology (US $ mln): Russia 1998 - 2008 Year
Russia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
3 3 3 3 4 4 4 4 5 5 6
5.50% 5.42% 5.35% 5.28% 5.22% 5.27% 5.34% 5.40% 5.47% 5.54% 5.61%
0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
135
Russia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
74 112 252 253 261 276 303 305 318 342 352 380 387 485 507
1.14 0.64 0.18 0.18 0.17 0.16 0.15 0.15 0.14 0.13 0.13 0.12 0.11 0.08 0.08 0.22 3.77
30.16 16.88 4.84 4.83 4.60 4.23 3.86 3.84 3.68 3.43 3.36 3.07 3.04 2.18 2.11 5.90 100.00
1.59 0.89 0.26 0.25 0.24 0.22 0.20 0.20 0.19 0.18 0.18 0.16 0.16 0.11 0.11 0.31 5.27
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Moscow Saint Petersburg Nizhni Novgorod Novosibirsk Yekaterinburg Kuybyshev Omsk Chelyabinsk Kazan Rostov-on-Don Volgograd Krasnoyark Saratov Vladivostok Irkutsk Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.36 SAN MARINO Biotechnology (US $ mln): San Marino 1998 - 2008 Year
San Marino
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
136
San Marino: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,695 1,812
0.00 0.00 0.01
63.64 36.36 100.00
0.01 0.00 0.01
0.00 0.00 0.00
_________________________________________________________________________________________________________
Serravalle San Marino Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
5.37 SLOVAKIA Biotechnology (US $ mln): Slovakia 1998 - 2008 Year
Slovakia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.50% 0.50% 0.51% 0.51% 0.51% 0.51% 0.51% 0.50% 0.50% 0.50% 0.49%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Slovakia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
334 725 772 837 1,001 1,102 1,340 1,345 1,348 1,363 1,390 1,391
0.13 0.05 0.04 0.04 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.37
35.87 12.79 11.54 9.82 6.81 5.21 3.15 3.12 3.06 2.97 2.83 2.83 100.00
0.18 0.07 0.06 0.05 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.51
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Prague Bratislava Brno Ostrava Kosice Plzen Olomouc Usti nad Labem Liberec Hradec Kralove Ceske Budejovice Pardubice Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
137
5.38 SLOVENIA Biotechnology (US $ mln): Slovenia 1998 - 2008 Year
Slovenia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.22% 0.22% 0.21% 0.21% 0.21% 0.21% 0.21% 0.22% 0.22% 0.22% 0.22%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Slovenia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
551 748 1,405 1,475 1,482 1,627 1,628
0.07 0.04 0.01 0.01 0.01 0.00 0.00 0.15
47.66 29.06 6.56 5.31 5.16 3.13 3.13 100.00
0.10 0.06 0.01 0.01 0.01 0.01 0.01 0.21
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Ljubljana Maribor Koper Kranj Celje Jesenice Trbovlje Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
138
5.39 SPAIN Biotechnology (US $ mln): Spain 1998 - 2008 Year
Spain
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
4 4 4 4 5 5 5 6 6 6 7
6.75% 6.74% 6.73% 6.71% 6.70% 6.71% 6.72% 6.74% 6.75% 6.76% 6.77%
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Spain: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
65 98 179 185 200 204 265 275 299 321 322 329 357 384 388
1.38 0.76 0.33 0.29 0.26 0.25 0.17 0.16 0.15 0.14 0.14 0.13 0.12 0.12 0.11 0.30 4.81
28.79 15.82 6.80 6.08 5.34 5.25 3.55 3.32 3.05 2.85 2.83 2.77 2.58 2.40 2.39 6.19 100.00
1.93 1.06 0.46 0.41 0.36 0.35 0.24 0.22 0.21 0.19 0.19 0.19 0.17 0.16 0.16 0.42 6.71
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
_________________________________________________________________________________________________________
Madrid Barcelona Valencia Sevilla Zaragoza Malaga Bilbao Las Palmas Valladolid Palma Murcia Cordoba Hospitalet Alicante Granada Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
139
5.40 SWEDEN Biotechnology (US $ mln): Sweden 1998 - 2008 Year
Sweden
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 2 2 2 2
1.86% 1.85% 1.84% 1.84% 1.83% 1.84% 1.84% 1.85% 1.85% 1.86% 1.87%
0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Sweden: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
173 224 379 494 627 632 633 634 663 679 700 729 749 753 830
0.33 0.22 0.12 0.08 0.06 0.06 0.06 0.06 0.05 0.05 0.05 0.05 0.04 0.04 0.04 1.32
25.41 16.37 8.81 6.15 4.56 4.52 4.52 4.52 4.18 4.06 3.84 3.53 3.38 3.34 2.81 100.00
0.47 0.30 0.16 0.11 0.08 0.08 0.08 0.08 0.08 0.07 0.07 0.06 0.06 0.06 0.05 1.84
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Stockholm Göteborg Malmö Uppsala Örebro Västeras Linköping Norrköping Jönköping Helsingborg Boras Sundsvall Umea Gävle Skelleftea Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
140
5.41 SWITZERLAND Biotechnology (US $ mln): Switzerland 1998 - 2008 Year
Switzerland
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 2 2 2 2
1.90% 1.91% 1.91% 1.92% 1.92% 1.92% 1.91% 1.91% 1.90% 1.90% 1.89%
0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Switzerland: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
161 251 260 301 328 451 520 605 669 802 815
0.37 0.18 0.17 0.15 0.13 0.09 0.08 0.06 0.05 0.04 0.04 1.37
27.10 13.44 12.66 10.66 9.73 6.56 5.64 4.63 3.94 2.86 2.78 100.00
0.52 0.26 0.24 0.20 0.19 0.13 0.11 0.09 0.08 0.05 0.05 1.92
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Zürich Basel Geneva Bern Lausanne Winterthur Saint Gallen Luzern Biel Thun Koniz Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
141
5.42 UKRAINE Biotechnology (US $ mln): Ukraine 1998 - 2008 Year
Ukraine
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 2 2 2
1.85% 1.83% 1.80% 1.78% 1.77% 1.78% 1.80% 1.82% 1.84% 1.86% 1.88%
0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Ukraine: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
211 302 405 417 418 499 558 590 722 736 739 804 860 879 882
0.24 0.15 0.11 0.10 0.10 0.08 0.07 0.06 0.05 0.05 0.05 0.04 0.03 0.03 0.03 0.09 1.27
18.44 11.48 8.40 7.95 7.91 6.30 5.63 5.08 3.68 3.58 3.54 3.06 2.67 2.54 2.53 7.20 100.00
0.33 0.20 0.15 0.14 0.14 0.11 0.10 0.09 0.07 0.06 0.06 0.05 0.05 0.05 0.05 0.13 1.78
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Kiev Kharkiv Dnipropetrovsk Odessa Donetsk Zaporozhye Lviv Krivoy Rog Mariupol (Zhdanov) Nikolayev Lugansk Makeyevka Vinnitsa Sevastopol Kherson Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
142
5.43 UNITED KINGDOM Biotechnology (US $ mln): United Kingdom 1998 - 2008 Year
United Kingdom
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
7 8 8 8 9 9 10 10 11 12 12
12.48% 12.52% 12.56% 12.60% 12.63% 12.61% 12.57% 12.53% 12.49% 12.45% 12.41%
0.04% 0.04% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
United Kingdom: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
47 84 86 101 102 133 146 156 159 167 171 183
3.16 0.88 0.87 0.73 0.73 0.47 0.42 0.38 0.38 0.36 0.34 0.30 9.02
35.03 9.73 9.67 8.09 8.09 5.21 4.65 4.25 4.22 3.95 3.73 3.36 100.00
4.42 1.23 1.22 1.02 1.02 0.66 0.59 0.54 0.53 0.50 0.47 0.42 12.61
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03
_________________________________________________________________________________________________________
London Birmingham Manchester Leeds Bradford Liverpool Sheffield Bristol Coventry Nottingham Leicester Hull Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
143
6 LATIN AMERICA: BIOTECHNOLOGY 6.1
EXECUTIVE SUMMARY Market Potential for Biotechnology in Latin America (US $ mln): 2003
Country
Latent Demand US $ mln
% of Latin America
8 6 3 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23
32.68% 26.83% 13.54% 7.19% 4.45% 4.21% 3.55% 1.33% 1.06% 0.87% 0.75% 0.72% 0.69% 0.60% 0.49% 0.48% 0.38% 0.10% 0.04% 0.03% 0.02% 0.00% 100.00%
_________________________________________________________________________________________________________
Brazil Mexico Argentina Colombia Chile Venezuela Peru Guatemala Ecuador Uruguay Paraguay Costa Rica El Salvador Bolivia Honduras Panama Nicaragua Guyana Suriname French Guiana Belize Falkland Islands Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
144
Market Potential for Biotechnology in Latin America (US $ mln): 2003 Argentina Mexico
Colombia
Other Brazil
The Market for Biotechnology in Latin America: 1998 - 2008 Year
US $ mln
% of Globe
19.53 20.01 20.50 21.01 21.66 23.08 24.72 26.49 28.38 30.42 32.60
0.11 0.10 0.09 0.09 0.08 0.08 0.08 0.08 0.07 0.07 0.07
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.2
145
ARGENTINA Biotechnology (US $ mln): Argentina 1998 - 2008
Year
Argentina
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
3 3 3 3 3 3 3 3 4 4 4
12.81% 13.05% 13.29% 13.53% 13.71% 13.54% 13.32% 13.11% 12.89% 12.68% 12.47%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Argentina: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
157 158 160 238 278 320 347 368 370 372 391 454 542 550 561
0.38 0.38 0.38 0.20 0.16 0.14 0.13 0.12 0.12 0.12 0.11 0.09 0.07 0.07 0.07 0.58 3.13
12.21 12.20 12.15 6.30 5.07 4.40 4.11 3.84 3.82 3.73 3.60 2.87 2.39 2.35 2.29 18.67 100.00
1.65 1.65 1.65 0.85 0.69 0.60 0.56 0.52 0.52 0.51 0.49 0.39 0.32 0.32 0.31 2.53 13.54
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Buenos Aires Santa Fe Cordoba Mendoza Tucumán Entre Rios Salta Rosario Misiones Chaco Corrientes Santiago del Estero Río Negro Jujuy San Juan Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.3
146
BELIZE Biotechnology (US $ mln): Belize 1998 - 2008
Year
Belize
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Belize: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,737 1,968 1,969 1,987 2,028
0.00 0.00 0.00 0.00 0.00 0.01
60.00 12.50 12.50 10.00 5.00 100.00
0.01 0.00 0.00 0.00 0.00 0.02
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Belize City Corozal Orange Walk Dangriga Belmopan Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.4
147
BOLIVIA Biotechnology (US $ mln): Bolivia 1998 - 2008
Year
Bolivia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.58% 0.59% 0.59% 0.60% 0.60% 0.60% 0.59% 0.59% 0.58% 0.58% 0.57%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Bolivia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
651 854 1,063 1,371 1,555 1,598 1,710
0.06 0.03 0.02 0.01 0.01 0.01 0.00 0.14
41.65 24.74 15.01 7.72 4.49 3.78 2.60 100.00
0.25 0.15 0.09 0.05 0.03 0.02 0.02 0.60
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
La Paz Santa Cruz Cochabamba Oruro Potosi Sucre Tarija Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.5
148
BRAZIL Biotechnology (US $ mln): Brazil 1998 - 2008
Year
Brazil
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
6 7 7 7 7 8 8 9 9 10 11
32.63% 32.65% 32.67% 32.68% 32.68% 32.68% 32.67% 32.65% 32.64% 32.62% 32.59%
0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Brazil: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
79 120 216 229 247 250 315 326 331 335 396 422 453 472 482
1.01 0.57 0.22 0.21 0.19 0.19 0.14 0.13 0.13 0.13 0.11 0.10 0.09 0.09 0.08 4.15 7.54
13.35 7.53 2.95 2.80 2.51 2.47 1.85 1.78 1.76 1.74 1.46 1.30 1.19 1.13 1.10 55.09 100.00
4.36 2.46 0.96 0.91 0.82 0.81 0.60 0.58 0.58 0.57 0.48 0.42 0.39 0.37 0.36 18.00 32.68
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03
_________________________________________________________________________________________________________
Sao Paulo Rio de Janeiro Salvador Belo Horizonte Fortaleza Brasilia Curitiba Recife Belem Pórto Alegre Manaus Goiânia Campinas Guarulhos Sao Gonçalo Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.6
149
CHILE Biotechnology (US $ mln): Chile 1998 - 2008
Year
Chile
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
4.54% 4.51% 4.48% 4.46% 4.44% 4.45% 4.48% 4.51% 4.53% 4.56% 4.58%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Chile: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
107 697 728 760 817 826 844 937 976 985 1,081 1,146
0.66 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02 1.03
64.14 4.92 4.53 4.21 3.70 3.62 3.40 2.79 2.55 2.52 1.93 1.69 100.00
2.86 0.22 0.20 0.19 0.16 0.16 0.15 0.12 0.11 0.11 0.09 0.08 4.45
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Santiago Concepcion Viña del Mar Valparaiso Talcahuano Temuco Antofagasta Rancagua Talca Arica Puerto Montt Punta Arenas Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.7
150
COLOMBIA Biotechnology (US $ mln): Colombia 1998 - 2008
Year
Colombia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 2 2 2 2 2 2 2 2
7.04% 7.09% 7.14% 7.19% 7.22% 7.19% 7.15% 7.10% 7.06% 7.02% 6.97%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Colombia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
100 218 226 465 468 741 775 820 873 888 1,012 1,109 1,177 1,206 1,240
0.75 0.22 0.21 0.09 0.09 0.05 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.03 1.66
45.36 13.10 12.81 5.21 5.16 2.71 2.53 2.28 1.99 1.91 1.46 1.12 0.99 0.92 0.87 1.58 100.00
3.26 0.94 0.92 0.37 0.37 0.20 0.18 0.16 0.14 0.14 0.11 0.08 0.07 0.07 0.06 0.11 7.19
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Bogota Cali Medell¡n Barranquilla Cartagena Bucaramanga Cucuta Pereira Manizales Ibague Armenia Santa Marta Neiva Pasto Monteria Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.8
151
COSTA RICA Biotechnology (US $ mln): Costa Rica 1998 - 2008
Year
Costa Rica
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.70% 0.71% 0.71% 0.72% 0.72% 0.72% 0.71% 0.71% 0.71% 0.70% 0.70%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Costa Rica: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
626 892 1,049 1,110 1,269 1,270 1,516
0.06 0.03 0.02 0.02 0.01 0.01 0.01 0.17
36.14 19.04 13.08 11.14 8.16 8.16 4.27 100.00
0.26 0.14 0.09 0.08 0.06 0.06 0.03 0.72
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
San Jose Alajuela Cartago Puntarenas Heredia Limon Liberia Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
6.9
152
ECUADOR Biotechnology (US $ mln): Ecuador 1998 - 2008
Year
Ecuador
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.00% 1.02% 1.04% 1.06% 1.07% 1.06% 1.04% 1.02% 1.01% 0.99% 0.97%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Ecuador: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
412 537 1,276 1,413 1,422 1,428 1,472 1,481 1,520
0.10 0.08 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.24
42.53 30.89 5.46 3.98 3.90 3.75 3.35 3.25 2.88 100.00
0.45 0.33 0.06 0.04 0.04 0.04 0.04 0.03 0.03 1.06
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Guayaquil Quito Cuenca Machala Portoviejo Riobamba Ambato Manta Esmeraldas Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
153
6.10 EL SALVADOR Biotechnology (US $ mln): El Salvador 1998 - 2008 Year
El Salvador
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.67% 0.68% 0.68% 0.69% 0.69% 0.69% 0.68% 0.68% 0.67% 0.67% 0.66%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
El Salvador: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
455 968 1,163 1,401 1,429 1,562
0.09 0.03 0.02 0.01 0.01 0.01 0.16
56.44 16.93 10.67 6.38 5.77 3.80 100.00
0.39 0.12 0.07 0.04 0.04 0.03 0.69
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
San Salvador Santa Ana San Miguel Nueva San Salvador Sonsonate Cojutepeque Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
154
6.11 FALKLAND ISLANDS Biotechnology (US $ mln): Falkland Islands 1998 - 2008 Year
Falkland Islands
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Falkland Islands: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
2,019
0.00 0.00
100.00 100.00
0.00 0.00
0.00 0.00
_________________________________________________________________________________________________________
Stanley Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
6.12 FRENCH GUIANA Biotechnology (US $ mln): French Guiana 1998 - 2008 Year
French Guiana
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
155
French Guiana: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,652 1,944 1,970 1,985 2,035
0.00 0.00 0.00 0.00 0.00 0.01
66.67 11.67 10.00 8.33 3.33 100.00
0.02 0.00 0.00 0.00 0.00 0.03
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Cayenne Kourou Remire Saint Laurent Sinnamary Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
6.13 GUATEMALA Biotechnology (US $ mln): Guatemala 1998 - 2008 Year
Guatemala
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.30% 1.31% 1.32% 1.33% 1.33% 1.33% 1.32% 1.31% 1.30% 1.30% 1.29%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Guatemala: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
212 1,172 1,197 1,394 1,403 1,425 1,426 1,464
0.23 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.31
74.02 5.39 5.11 3.36 3.29 3.08 3.01 2.73 100.00
0.98 0.07 0.07 0.04 0.04 0.04 0.04 0.04 1.33
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Guatemala City Escuintla Quezaltenango Puerto Barrios Retalhuleu Coban Chiquimula Mazatenango Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
156
6.14 GUYANA Biotechnology (US $ mln): Guyana 1998 - 2008 Year
Guyana
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.09%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Guyana: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,162 1,774 1,851 1,922 2,000
0.02 0.00 0.00 0.00 0.00 0.02
75.19 11.28 7.52 4.14 1.88 100.00
0.07 0.01 0.01 0.00 0.00 0.10
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Georgetown Linden New Amsterdam Corriverton Mahaicony Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
157
6.15 HONDURAS Biotechnology (US $ mln): Honduras 1998 - 2008 Year
Honduras
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.50% 0.50% 0.50% 0.49% 0.49% 0.49% 0.50% 0.50% 0.50% 0.50% 0.50%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Honduras: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
696 858 1,596 1,602 1,621 1,728 1,773 1,804 1,818 1,853 1,859
0.05 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11
44.79 29.98 4.61 4.54 4.26 2.94 2.24 1.96 1.82 1.47 1.40 100.00
0.22 0.15 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.49
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Tegucigalpa San Pedro Sula La Ceiba Choluteca El Progreso Puerto Cortes Comayagua Tela Siguatepeque Santa Rosa de Copan Danli Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
158
6.16 MEXICO Biotechnology (US $ mln): Mexico 1998 - 2008 Year
Mexico
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
5 6 6 6 6 6 7 7 8 9 9
28.03% 27.63% 27.24% 26.85% 26.56% 26.83% 27.18% 27.54% 27.89% 28.26% 28.62%
0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Mexico: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
58 170 201 203 214 223 230 234 308 309 312 337 341 367 369
1.76 0.34 0.26 0.25 0.23 0.22 0.21 0.21 0.14 0.14 0.14 0.13 0.13 0.12 0.12 1.79 6.19
28.42 5.47 4.13 4.10 3.64 3.49 3.39 3.32 2.33 2.33 2.30 2.10 2.10 1.95 1.94 28.99 100.00
7.62 1.47 1.11 1.10 0.98 0.94 0.91 0.89 0.63 0.63 0.62 0.56 0.56 0.52 0.52 7.78 26.83
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02
_________________________________________________________________________________________________________
Mexico City Guadalajara Nezahualcoyotl Puebla Monterrey Leon Ciudad Juarez Tijuana Culiacan Mexicali Acapulco Chihuahua S. Luis Potosi Aguascalientes Morelia Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
159
6.17 NICARAGUA Biotechnology (US $ mln): Nicaragua 1998 - 2008 Year
Nicaragua
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.39% 0.39%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Nicaragua: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
781 1,085 1,557 1,589 1,639 1,665 1,800 1,817 1,836
0.04 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.09
47.30 22.54 7.00 6.17 5.20 4.72 2.57 2.36 2.15 100.00
0.18 0.09 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.38
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Managua Rosita Leon Granada Masaya Chinandega Matagalpa San Carlos Esteli Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
160
6.18 PANAMA Biotechnology (US $ mln): Panama 1998 - 2008 Year
Panama
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.46% 0.47% 0.47% 0.48% 0.48% 0.48% 0.47% 0.47% 0.46% 0.46% 0.46%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Panama: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
572 1,336 1,462 1,492 1,612 1,617 1,849 1,858
0.07 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.11
62.90 10.55 7.64 6.94 4.51 4.46 1.54 1.46 100.00
0.30 0.05 0.04 0.03 0.02 0.02 0.01 0.01 0.48
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Panama Colon David La Chorrera Penonome Santiago Bocas del Toro Tocumen Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
161
6.19 PARAGUAY Biotechnology (US $ mln): Paraguay 1998 - 2008 Year
Paraguay
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.71% 0.72% 0.73% 0.75% 0.75% 0.75% 0.73% 0.72% 0.71% 0.70% 0.69%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Paraguay: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
413 1,198 1,346 1,347 1,400 1,651 1,699 1,700 1,741 1,742 1,757
0.10 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.17
59.85 9.03 6.57 6.57 5.91 2.55 2.13 2.13 1.81 1.81 1.64 100.00
0.45 0.07 0.05 0.05 0.04 0.02 0.02 0.02 0.01 0.01 0.01 0.75
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Asuncion Puerto Stroessner Pedro Juan Caballero San Lorenzo Fernando de la Mora Encarnacion Concepción Pilar Villarrica Coronel Oviedo Caaguazu Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
162
6.20 PERU Biotechnology (US $ mln): Peru 1998 - 2008 Year
Peru
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
3.51% 3.52% 3.53% 3.55% 3.55% 3.55% 3.54% 3.52% 3.51% 3.50% 3.49%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Peru: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
135 639 659 706 799 925 955 994 1,004 1,084 1,234 1,251
0.46 0.06 0.06 0.05 0.04 0.03 0.03 0.03 0.02 0.02 0.01 0.01 0.82
56.10 7.21 6.82 5.98 4.81 3.62 3.40 3.11 3.02 2.42 1.78 1.72 100.00
1.99 0.26 0.24 0.21 0.17 0.13 0.12 0.11 0.11 0.09 0.06 0.06 3.55
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Lima Arequipa Callao Trujillo Chiclayo Piura Chimbote Cuzco Iquitos Huancayo Sullana Pucallpa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
163
6.21 SURINAME Biotechnology (US $ mln): Suriname 1998 - 2008 Year
Suriname
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Suriname: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,461 1,972 2,022 2,051 2,059
0.01 0.00 0.00 0.00 0.00 0.01
87.39 6.72 3.36 1.68 0.84 100.00
0.04 0.00 0.00 0.00 0.00 0.04
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Paramaribo Nieuw Nickerie Marienburg Moengo Totness Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
164
6.22 URUGUAY Biotechnology (US $ mln): Uruguay 1998 - 2008 Year
Uruguay
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.80% 0.82% 0.85% 0.87% 0.89% 0.87% 0.85% 0.83% 0.81% 0.79% 0.77%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Uruguay: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
294 1,412 1,434 1,508 1,535 1,607 1,624 1,646 1,657
0.15 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.20
74.51 4.84 4.48 3.64 3.34 2.51 2.39 2.21 2.09 100.00
0.65 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.87
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Montevideo Salto Paysandu Las Piedras Rivera Melo Tacuarembo Mercedes Minas Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
165
6.23 VENEZUELA Biotechnology (US $ mln): Venezuela 1998 - 2008 Year
Venezuela
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
4.14% 4.16% 4.18% 4.21% 4.22% 4.21% 4.19% 4.17% 4.14% 4.12% 4.10%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Venezuela: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
197 421 461 580 664 809 821 989 1,011 1,075 1,083 1,092 1,097 1,106 1,137
0.26 0.10 0.09 0.07 0.05 0.04 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.16 0.97
26.70 10.15 9.01 6.80 5.65 3.97 3.89 2.65 2.51 2.08 2.04 1.99 1.98 1.95 1.81 16.83 100.00
1.12 0.43 0.38 0.29 0.24 0.17 0.16 0.11 0.11 0.09 0.09 0.08 0.08 0.08 0.08 0.71 4.21
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Caracas Maracaibo Valencia Maracay Barquisimeto Petare Ciudad Guayana San Cristobal La Guaira Baruta Ciudad Bolivar Maturin Merida Cumana Barcelona Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
166
7 NORTH AMERICA & THE CARIBBEAN: BIOTECHNOLOGY 7.1
EXECUTIVE SUMMARY
Market Potential for Biotechnology in North America & the Caribbean (US $ mln): 2003 Country
Latent Demand US $ mln % of North America & the Caribbean
_________________________________________________________________________________________________________
United States Canada Dominican Republic Puerto Rico Cuba Haiti Trinidad and Tobago Jamaica Bahamas Martinique Barbados Guadeloupe Netherlands Antilles Bermuda Aruba Virgin Islands, US Greenland Cayman Islands St. Lucia Antigua and Barbuda Grenada St. Vincent and the Grenadines British Virgin Islands Dominica St. Kitts and Nevis Other Total
28,484 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 28,490
99.98% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
167
Market Potential for Biotechnology in North America & the Caribbean (US $ mln): 2003
United States Other Canada Dominican Republic Puerto Rico
The Market for Biotechnology in North America & the Caribbean: 1998 - 2008 Year
US $ mln
% of Globe
17,691.42 19,460.15 21,405.76 23,545.91 25,900.10 28,489.91 31,338.72 34,472.40 37,919.43 41,711.16 45,882.04
99.04 99.10 99.15 99.20 99.24 99.26 99.28 99.30 99.31 99.33 99.34
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
7.2
168
ANTIGUA AND BARBUDA Biotechnology (US $ mln): Antigua and Barbuda 1998 - 2008
Year
Antigua and Barbuda
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Antigua and Barbuda: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,719 2,057
0.00 0.00 0.00
97.30 2.70 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Saint John's Codrington Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.3
ARUBA Biotechnology (US $ mln): Aruba 1998 - 2008
Year
Aruba
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
169
Aruba: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,513 1,558
0.01 0.01 0.01
54.05 45.95 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Oranjestad Sint Nicolaas Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.4
BAHAMAS Biotechnology (US $ mln): Bahamas 1998 - 2008
Year
Bahamas
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Bahamas: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
993 1,642
0.03 0.00 0.03
84.91 15.09 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Nassau Freeport Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
7.5
170
BARBADOS Biotechnology (US $ mln): Barbados 1998 - 2008
Year
Barbados
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Barbados: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
974
0.03 0.03
100.00 100.00
0.00 0.00
0.00 0.00
_________________________________________________________________________________________________________
Bridgetown Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.6
BERMUDA Biotechnology (US $ mln): Bermuda 1998 - 2008
Year
Bermuda
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
171
Bermuda: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,467 1,583
0.01 0.01 0.01
60.00 40.00 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Hamilton Saint George Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.7
CANADA Biotechnology (US $ mln): Canada 1998 - 2008
Year
Canada
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
4 4 5 5 5 5 6 6 6 7 7
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
172
Canada: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
60 67 113 162 186 194 198 319 509 543 694 699 758 877 922
1.55 1.32 0.62 0.37 0.29 0.27 0.26 0.14 0.08 0.07 0.05 0.05 0.04 0.03 0.03 5.17
29.90 25.49 12.05 7.15 5.55 5.19 5.01 2.68 1.53 1.44 0.99 0.98 0.84 0.63 0.58 100.00
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
_________________________________________________________________________________________________________
Toronto Montreal Vancouver Ottawa Calgary Winnipeg Edmonton Hamilton Regina Quebec Halifax Thunder Bay Saint John's Niagara Falls Victoria Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.8
CAYMAN ISLANDS Biotechnology (US $ mln): Cayman Islands 1998 - 2008
Year
Cayman Islands
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
173
Cayman Islands: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,707 1,842 1,989 2,029
0.00 0.00 0.00 0.00 0.01
58.33 29.17 8.33 4.17 100.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
George Town West Bay Savannah Bodden Town Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.9
CUBA Biotechnology (US $ mln): Cuba 1998 - 2008
Year
Cuba
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
174
Cuba: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
573 1,289 1,433 1,512 1,546 1,554 1,675 1,685 1,696 1,698 1,702
0.07 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.13
52.92 10.02 7.07 5.60 4.96 4.83 3.06 2.98 2.88 2.85 2.83 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Havana Santiago de Cuba Camagüey Holguin Guantanamo Santa Clara Bayamo Cienfuegos Pinar del Rio Las Tunas Matanzas Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.10 DOMINICA Biotechnology (US $ mln): Dominica 1998 - 2008 Year
Dominica
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
175
Dominica: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,893 2,047 2,048 2,049 2,050
0.00 0.00 0.00 0.00 0.00 0.00
64.71 8.82 8.82 8.82 8.82 100.00
0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Roseau Saint Joseph Portsmouth Marigot Berekua Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.11 DOMINICAN REPUBLIC Biotechnology (US $ mln): Dominican Republic 1998 - 2008 Year
Dominican Republic
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 1
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Dominican Republic: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
0.21 0.04 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.33
64.68 13.07 4.63 4.13 3.85 2.94 2.29 2.29 2.11 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Santo Domingo Santiago La Romana San Pedro de Macoris San Francisco de Macoris La Vega Barahona San Juan Puerto Plata Total
227 765 1,213 1,268 1,301 1,418 1,499 1,500 1,527
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
176
7.12 GREENLAND Biotechnology (US $ mln): Greenland 1998 - 2008 Year
Greenland
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Greenland: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,819 1,929 1,964 1,990 1,991 1,992 2,016 2,017 2,018 2,040 2,041 2,042 2,043 2,044 2,045
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
28.57 11.90 9.52 7.14 7.14 7.14 4.76 4.76 4.76 2.38 2.38 2.38 2.38 2.38 2.38 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Nuuk Holsteinsborg Jakobshavn Julianehab Egedesminde Sukkertoppen Narsarsuaq Frederikshab Christianshab Uppernavik Thule Scoresbysund Godhavn Ammassalik Nanortalik Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
177
7.13 GRENADA Biotechnology (US $ mln): Grenada 1998 - 2008 Year
Grenada
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Grenada: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,811 1,986
0.00 0.00 0.00
80.00 20.00 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Saint George's Gouyave Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.14 GUADELOUPE Biotechnology (US $ mln): Guadeloupe 1998 - 2008 Year
Guadeloupe
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
178
Guadeloupe: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,515 1,749 1,789 1,822 1,833 1,844 1,850 1,860 1,861 1,903
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02
29.44 12.15 9.81 8.41 7.94 7.48 7.01 6.54 6.54 4.67 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Les Abymes Pointe-a-Pitre Le Gosier Moule Sainte Anne Morne-a-l'Eau Petit Bourg Sainte Rose Basse-Terre Saint-Claude Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.15 HAITI Biotechnology (US $ mln): Haiti 1998 - 2008 Year
Haiti
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
179
Haiti: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
642 1,456 1,637 1,644 1,645 1,767
0.06 0.01 0.00 0.00 0.00 0.00 0.08
70.39 10.12 5.51 5.36 5.36 3.27 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Port-au-Prince Cap-Haitien Petionville Gonaives Les Cayes Port-de-Paix Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.16 JAMAICA Biotechnology (US $ mln): Jamaica 1998 - 2008 Year
Jamaica
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Jamaica: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
761 1,509 1,574 1,727 1,753 1,899
0.04 0.01 0.01 0.00 0.00 0.00 0.06
67.83 11.50 9.04 5.30 4.52 1.81 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Kingston Spanish Town Montego Bay May Pen Mandeville Savanna-la-Mar Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
180
7.17 MARTINIQUE Biotechnology (US $ mln): Martinique 1998 - 2008 Year
Martinique
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Martinique: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,204 1,691 1,779 1,802 1,826 1,878 1,961 1,962
0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03
53.66 13.17 8.78 7.80 6.83 4.88 2.44 2.44 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Fort-de-France Le Lamentin Sainte Marie Schoelcher Le François La Trinité Ducos Saint Pierre Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
181
7.18 NETHERLANDS ANTILLES Biotechnology (US $ mln): Netherlands Antilles 1998 - 2008 Year
Netherlands Antilles
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Netherlands Antilles: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,232 1,958 2,054
0.01 0.00 0.00 0.02
94.70 4.55 0.76 100.00
0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Willemstad Philipsburg Kralendijk Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
182
7.19 PUERTO RICO Biotechnology (US $ mln): Puerto Rico 1998 - 2008 Year
Puerto Rico
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Puerto Rico: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
635 887 984 988 1,096 1,241 1,260 1,261 1,297 1,399 1,442 1,523 1,573 1,595 1,648
0.06 0.03 0.03 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.26
22.99 12.29 10.07 9.99 7.43 5.56 5.35 5.34 4.91 3.96 3.46 2.69 2.23 2.03 1.72 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
San Juan Bayamon Ponce Carolina Caguas Guaynabo Mayaguez Arecibo Toa Baja Trujillo Alto Aguadilla Cayey Guayama Fajardo Catano Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
183
7.20 ST. KITTS AND NEVIS Biotechnology (US $ mln): St. Kitts and Nevis 1998 - 2008 Year
St. Kitts and Nevis
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
St. Kitts and Nevis: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,848 2,058
0.00 0.00 0.00
95.00 5.00 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Basseterre Charlestown Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.21 ST. LUCIA Biotechnology (US $ mln): St. Lucia 1998 - 2008 Year
St. Lucia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
184
St. Lucia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,687 1,938
0.00 0.00 0.00
82.81 17.19 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Castries Vieux Fort Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
7.22 ST. VINCENT AND THE GRENADINES Biotechnology (US $ mln): St. Vincent and the Grenadines 1998 - 2008 Year St. Vincent and the Grenadines
% of Region
% of Globe
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
St. Vincent and the Grenadines: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,823 2,055
0.00 0.00 0.00
95.00 5.00 100.00
0.00 0.00 0.00
0.00 0.00 0.00
_________________________________________________________________________________________________________
Kingstown Georgetown Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
185
7.23 TRINIDAD AND TOBAGO Biotechnology (US $ mln): Trinidad and Tobago 1998 - 2008 Year
Trinidad and Tobago
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Trinidad and Tobago: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
853 1,078 1,156 1,714
0.03 0.02 0.02 0.00 0.08
45.67 26.77 22.83 4.72 100.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Port-of-Spain San Fernando Arima Scarborough Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
186
7.24 UNITED STATES Biotechnology (US $ mln): United States 1998 - 2008 Year
United States
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
17,686 19,455 21,400 23,540 25,894 28,484 31,332 34,465 37,912 41,703 45,873
99.97% 99.97% 99.97% 99.98% 99.98% 99.98% 99.98% 99.98% 99.98% 99.98% 99.98%
99.01% 99.07% 99.12% 99.17% 99.22% 99.24% 99.26% 99.27% 99.29% 99.31% 99.32%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
United States: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
6,479.54 2,345.60 2,156.08 1,255.01 1,112.52 794.67 785.54 773.33 752.46 721.24 716.93 600.05 511.72 477.72 465.36 8,535.81 28483.60
22.75 8.23 7.57 4.41 3.91 2.79 2.76 2.71 2.64 2.53 2.52 2.11 1.80 1.68 1.63 29.97 100.00
22.74 8.23 7.57 4.41 3.90 2.79 2.76 2.71 2.64 2.53 2.52 2.11 1.80 1.68 1.63 29.96 99.98
22.58 8.17 7.51 4.37 3.88 2.77 2.74 2.69 2.62 2.51 2.50 2.09 1.78 1.66 1.62 29.74 99.24
_________________________________________________________________________________________________________
New York Los Angeles Chicago Houston Philadelphia Dallas San Jose San Francisco San Diego Detroit Phoenix San Antonio Indianapolis Baltimore Washington D.C. Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
187
7.25 VIRGIN ISLANDS, US Biotechnology (US $ mln): Virgin Islands, US 1998 - 2008 Year
Virgin Islands, US
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Virgin Islands, US: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,531 1,874 1,875 1,908 1,956 2,014
0.01 0.00 0.00 0.00 0.00 0.00 0.01
57.58 12.12 12.12 9.09 6.06 3.03 100.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Charlotte Amalie Road Town Frederiksted Christiansted Cruz Bay Spanish Town Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
188
8 OCEANA: BIOTECHNOLOGY 8.1
EXECUTIVE SUMMARY Market Potential for Biotechnology in Oceana (US $ mln): 2003
Country
Latent Demand US $ mln
% of Oceana
_________________________________________________________________________________________________________
Australia New Zealand Fiji Guam New Caledonia French Polynesia Solomon Islands Northern Mariana Island Western Samoa American Samoa Micronesia Federation Vanuatu Tonga Palau Marshall Islands Cook Island Kiribati Nauru Norfolk Island Pacific Islands Trust Christmas Island Wallis and Futuna Tuvalu Niue Tokelau Other Total
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4
83.88% 12.65% 1.04% 0.59% 0.56% 0.48% 0.17% 0.17% 0.11% 0.09% 0.05% 0.04% 0.04% 0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 100.00%
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
189
Market Potential for Biotechnology in Oceana (US $ mln): 2003
New Zealand Fiji Guam Other Australia
The Market for Biotechnology in Oceana: 1998 - 2008 Year
US $ mln
% of Globe
3.01 3.09 3.16 3.24 3.33 3.56 3.81 4.08 4.38 4.69 5.03
0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
8.2
190
AMERICAN SAMOA Biotechnology (US $ mln): American Samoa 1998 - 2008
Year
American Samoa
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.08% 0.08%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
American Samoa: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,907 1,953 1,954 2,011 2,012
0.00 0.00 0.00 0.00 0.00 0.00
33.33 22.22 22.22 11.11 11.11 100.00
0.03 0.02 0.02 0.01 0.01 0.09
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Pago Pago Leone Fagatogo Utulei Vaitogi Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
8.3
191
AUSTRALIA Biotechnology (US $ mln): Australia 1998 - 2008
Year
Australia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
3 3 3 3 3 3 3 3 4 4 4
84.32% 84.18% 84.04% 83.89% 83.78% 83.88% 84.02% 84.15% 84.28% 84.40% 84.52%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Australia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
85 87 125 190 314 441 747 750 900 1,048 1,086 1,173 1,237
0.87 0.86 0.54 0.27 0.14 0.09 0.04 0.04 0.03 0.02 0.02 0.02 0.01 2.98
29.32 28.92 18.26 9.21 4.70 3.15 1.49 1.49 1.03 0.73 0.66 0.55 0.49 100.00
24.59 24.26 15.32 7.73 3.94 2.64 1.25 1.25 0.87 0.61 0.55 0.46 0.41 83.88
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Sydney Melbourne Brisbane Perth Adelaide Canberra Newcastle Gold Coast Hobart Wollongong Townsville Darwin Geelong Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
8.4
192
FIJI Biotechnology (US $ mln): Fiji 1998 - 2008
Year
Fiji
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.85% 0.91% 0.97% 1.04% 1.09% 1.04% 0.98% 0.93% 0.87% 0.82% 0.78%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Fiji: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
Suva Nadi
863 1,724
0.03 0.00 0.04
90.91 9.09 100.00
0.95 0.09 1.04
0.00 0.00 0.00
_________________________________________________________________________________________________________
Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.5
FRENCH POLYNESIA Biotechnology (US $ mln): French Polynesia 1998 - 2008
Year
French Polynesia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.47% 0.47% 0.48% 0.48% 0.49% 0.48% 0.48% 0.48% 0.47% 0.47% 0.46%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
193
French Polynesia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,438 1,693 1,801 1,904 1,947 2,008
0.01 0.00 0.00 0.00 0.00 0.00 0.02
52.17 21.74 13.04 6.52 4.35 2.17 100.00
0.25 0.11 0.06 0.03 0.02 0.01 0.48
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Papeete Mahina Papara Mataiea Afareaitu Teahupoo Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.6
GUAM Biotechnology (US $ mln): Guam 1998 - 2008
Year
Guam
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.55% 0.56% 0.57% 0.59% 0.60% 0.59% 0.58% 0.57% 0.55% 0.54% 0.53%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Guam: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,385 1,587 1,682 1,945 2,007
0.01 0.01 0.00 0.00 0.00 0.02
49.80 26.17 18.61 3.63 1.79 100.00
0.29 0.15 0.11 0.02 0.01 0.59
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Dededo Tamuning Santa Rita Talofofo Agana Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
8.7
194
KIRIBATI Biotechnology (US $ mln): Kiribati 1998 - 2008
Year
Kiribati
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Kiribati: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,994
0.00 0.00
100.00 100.00
0.01 0.01
0.00 0.00
_________________________________________________________________________________________________________
Tarawa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.8
NAURU Biotechnology (US $ mln): Nauru 1998 - 2008
Year
Nauru
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
195
Nauru: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
2,002
0.00 0.00
100.00 100.00
0.01 0.01
0.00 0.00
_________________________________________________________________________________________________________
Yaren Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.9
NEW CALEDONIA Biotechnology (US $ mln): New Caledonia 1998 - 2008
Year
New Caledonia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.55% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.55% 0.55% 0.55%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
New Caledonia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,209 1,882 1,924 1,925 1,963 1,997 2,031
0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.02
76.74 6.98 4.65 4.65 3.49 2.33 1.16 100.00
0.43 0.04 0.03 0.03 0.02 0.01 0.01 0.56
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Noumea Dumbea Canala Bourail Thio Hienghene Houailu Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
196
8.10 NEW ZEALAND Biotechnology (US $ mln): New Zealand 1998 - 2008 Year
New Zealand
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 1 1 1 1
12.50% 12.55% 12.60% 12.65% 12.69% 12.65% 12.61% 12.56% 12.52% 12.47% 12.43%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
New Zealand: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
263 652 657 963 1,091 1,099 1,145 1,246 1,296 1,430 1,448 1,455 1,460 1,496 1,517
0.17 0.06 0.06 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.45
38.01 12.80 12.46 6.06 4.32 4.25 3.87 3.15 2.83 2.03 1.94 1.89 1.87 1.69 1.57 1.25 100.00
4.81 1.62 1.58 0.77 0.55 0.54 0.49 0.40 0.36 0.26 0.25 0.24 0.24 0.21 0.20 0.16 12.65
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Auckland Wellington Christchurch Hamilton Napier-Hastings Dunedin Waitemata Tauranga Palmerston North Rotorua Nelson Invercargill New Plymouth Whangarei Wanganui Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
197
8.11 NORTHERN MARIANA ISLAND Biotechnology (US $ mln): Northern Mariana Island 1998 - 2008 Year
Northern Mariana Island
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.15% 0.16% 0.16% 0.17% 0.17% 0.17% 0.16% 0.16% 0.16% 0.15% 0.15%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Northern Mariana Island: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,569
0.01 0.01
100.00 100.00
0.17 0.17
0.00 0.00
_________________________________________________________________________________________________________
Saipan Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.12 SOLOMON ISLANDS Biotechnology (US $ mln): Solomon Islands 1998 - 2008 Year
Solomon Islands
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.16% 0.16% 0.16% 0.17% 0.17% 0.17% 0.16% 0.16% 0.16% 0.16% 0.15%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
198
Solomon Islands: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,568
0.01 0.01
100.00 100.00
0.17 0.17
0.00 0.00
_________________________________________________________________________________________________________
Honiara Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.13 TONGA Biotechnology (US $ mln): Tonga 1998 - 2008 Year
Tonga
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Tonga: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,868
0.00 0.00
100.00 100.00
0.04 0.04
0.00 0.00
_________________________________________________________________________________________________________
Nuku'alofa Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
199
8.14 TUVALU Biotechnology (US $ mln): Tuvalu 1998 - 2008 Year
Tuvalu
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Tuvalu: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
2,060
0.00 0.00
100.00 100.00
0.00 0.00
0.00 0.00
_________________________________________________________________________________________________________
Funafuti Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.15 VANUATU Biotechnology (US $ mln): Vanuatu 1998 - 2008 Year
Vanuatu
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.04% 0.04% 0.04% 0.04% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
200
Vanuatu: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
1,862
0.00 0.00
100.00 100.00
0.04 0.04
0.00 0.00
_________________________________________________________________________________________________________
Port Vila Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
8.16 WESTERN SAMOA Biotechnology (US $ mln): Western Samoa 1998 - 2008 Year
Western Samoa
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Western Samoa: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
Apia
1,684
0.00 0.00
100.00 100.00
0.11 0.11
0.00 0.00
_________________________________________________________________________________________________________
Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
201
9 THE MIDDLE EAST: BIOTECHNOLOGY 9.1
EXECUTIVE SUMMARY Market Potential for Biotechnology in the Middle East (US $ mln): 2003
Country
Latent Demand US $ mln
% of the Middle East
3 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12
25.94% 16.38% 13.43% 11.89% 6.43% 3.47% 3.44% 3.12% 2.94% 1.71% 1.41% 1.20% 1.19% 1.14% 1.04% 0.99% 0.87% 0.84% 0.74% 0.59% 0.58% 0.42% 0.17% 0.06% 100.00%
_________________________________________________________________________________________________________
Turkey Pakistan Saudi Arabia Iran Israel Iraq Uzbekistan United Arab Emirates Syrian Arab Republic Kuwait Azerbaijan Turkmenistan Afghanistan Oman Lebanon Jordan Qatar Yemen Kyrgyzstan Bahrain Armenia Tajikistan West Bank Gaza Strip Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
202
Market Potential for Biotechnology in the Middle East (US $ mln): 2003 Saudi Arabia
Iran
Pakistan
Other Turkey
The Market for Biotechnology in the Middle East: 1998 - 2008 Year
US $ mln
% of Globe
9.89 10.09 10.29 10.49 10.78 11.52 12.39 13.34 14.35 15.45 16.63
0.06 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04
_________________________________________________________________________________________________________
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.2
203
AFGHANISTAN Biotechnology (US $ mln): Afghanistan 1998 - 2008
Year
Afghanistan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.10% 1.13% 1.16% 1.19% 1.21% 1.19% 1.16% 1.14% 1.11% 1.08% 1.05%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Afghanistan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
460 1,255 1,358 1,476 1,711 1,715 1,775 1,782 1,821 1,824
0.09 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.14
64.17 10.18 7.98 5.90 2.61 2.57 1.85 1.80 1.49 1.44 100.00
0.77 0.12 0.10 0.07 0.03 0.03 0.02 0.02 0.02 0.02 1.19
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Kabul Qandahar Herat Mazar-e-Sharif Jalalabad Qonduz Baghlan Meymaneh Pol-e-Khomri Ghazni Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.3
204
ARMENIA Biotechnology (US $ mln): Armenia 1998 - 2008
Year
Armenia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Armenia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
818 1,551 1,600 1,830 1,840 1,843 1,872 1,886 1,905 1,913 1,915 1,936 1,937 1,940 1,941
0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07
56.57 9.39 7.74 2.89 2.75 2.70 2.15 2.02 1.65 1.51 1.47 1.24 1.24 1.15 1.15 4.40 100.00
0.33 0.05 0.05 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.03 0.58
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Yerevan Gyumri Kirovakan Hrazdan Echmiadzin Abovian Kaphan Hoktemberian Charentsavan Artashat Kamo Sevan Goris Massis Ashtarak Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.4
205
AZERBAIJAN Biotechnology (US $ mln): Azerbaijan 1998 - 2008
Year
Azerbaijan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.55% 1.50% 1.46% 1.41% 1.38% 1.41% 1.45% 1.49% 1.53% 1.58% 1.62%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Azerbaijan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
393 1,128 1,229 1,643 1,722 1,733 1,768 1,803 1,895
0.11 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.16
69.28 10.96 9.11 2.76 2.09 2.01 1.66 1.38 0.75 100.00
0.98 0.15 0.13 0.04 0.03 0.03 0.02 0.02 0.01 1.41
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Baku Gyandzha Sumgait Mingechaur Sheki Nakhichevan Lenkoran Stepanakert Shemakha Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.5
206
BAHRAIN Biotechnology (US $ mln): Bahrain 1998 - 2008
Year
Bahrain
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.58% 0.58%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Bahrain: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
864 1,153 1,375 1,635 1,864
0.03 0.02 0.01 0.00 0.00 0.07
49.67 25.49 15.69 6.86 2.29 100.00
0.29 0.15 0.09 0.04 0.01 0.59
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Manama Muharraq Jidd Hafs Isa Town Al Hidd Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.6
207
IRAN Biotechnology (US $ mln): Iran 1998 - 2008
Year
Iran
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 2 2 2 2
11.49% 11.62% 11.75% 11.88% 11.98% 11.89% 11.77% 11.65% 11.53% 11.41% 11.29%
0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Iran: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
117 313 433 438 483 654 667 685 695 932 940 945 999 1,039 1,088
0.59 0.14 0.10 0.09 0.08 0.06 0.05 0.05 0.05 0.03 0.03 0.03 0.02 0.02 0.02 1.37
42.86 10.38 7.00 6.89 6.01 4.11 3.98 3.85 3.74 2.13 2.09 2.06 1.82 1.63 1.43 100.00
5.10 1.23 0.83 0.82 0.72 0.49 0.47 0.46 0.44 0.25 0.25 0.25 0.22 0.19 0.17 11.89
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Tehran Mashad Isfahan Tabriz Shiraz Ahvaz Bakhtaran Qom Karaj Orumiyeh Abadan Rasht Kerman Yazd Bandar 'Abbas Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.7
208
IRAQ Biotechnology (US $ mln): Iraq 1998 - 2008
Year
Iraq
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 1 1 1 1
4.03% 3.84% 3.66% 3.48% 3.36% 3.47% 3.63% 3.80% 3.97% 4.15% 4.33%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Iraq: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
213 916 956 980 1,180 1,267 1,330 1,380 1,436 1,533 1,538 1,545 1,582 1,746
0.23 0.03 0.03 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.40
56.60 7.51 6.95 6.51 4.07 3.40 2.96 2.62 2.25 1.69 1.67 1.61 1.40 0.75 100.00
1.97 0.26 0.24 0.23 0.14 0.12 0.10 0.09 0.08 0.06 0.06 0.06 0.05 0.03 3.47
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Baghdad Basra Mosul Kirkuk Irbil As-Sulaymaniyah An-Najaf Al-Hillah Karbala An-Nasiriyah Ar-Ramadi Al-Amarah Ba'qubah Samarra Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.8
209
ISRAEL Biotechnology (US $ mln): Israel 1998 - 2008
Year
Israel
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 1 1 1 1 1 1
6.50% 6.48% 6.46% 6.44% 6.42% 6.43% 6.46% 6.48% 6.50% 6.52% 6.53%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Israel: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
225 300 415 598 625 680 686 714
0.21 0.15 0.10 0.06 0.06 0.05 0.05 0.05 0.74
28.97 19.77 13.77 8.65 8.09 7.16 7.10 6.49 100.00
1.86 1.27 0.89 0.56 0.52 0.46 0.46 0.42 6.43
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Jerusalem Tel Aviv Haifa Holon Petach-Tikva Ramat Gan Beersheba Bene Beraq Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
9.9
210
JORDAN Biotechnology (US $ mln): Jordan 1998 - 2008
Year
Jordan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.94% 0.96% 0.97% 0.99% 1.00% 0.99% 0.98% 0.96% 0.95% 0.93% 0.92%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Jordan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
602 1,047 1,341 1,423 1,729 1,794 1,839
0.06 0.02 0.01 0.01 0.00 0.00 0.00 0.11
55.97 19.09 10.07 8.33 2.92 1.99 1.62 100.00
0.56 0.19 0.10 0.08 0.03 0.02 0.02 0.99
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Amman Zarqa Irbid Salt Ajlun Jarash Madaba Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
211
9.10 KUWAIT Biotechnology (US $ mln): Kuwait 1998 - 2008 Year
Kuwait
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.73% 1.73% 1.72% 1.71% 1.71% 1.71% 1.72% 1.72% 1.73% 1.74% 1.74%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Kuwait: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
579 608 712 1,098
0.07 0.06 0.05 0.02 0.20
33.77 32.01 24.50 9.71 100.00
0.58 0.55 0.42 0.17 1.71
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Salmiya Hawalli Jahra Kuwait Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
212
9.11 KYRGYZSTAN Biotechnology (US $ mln): Kyrgyzstan 1998 - 2008 Year
Kyrgyzstan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.74% 0.74% 0.74% 0.74% 0.73% 0.74% 0.74% 0.74% 0.74% 0.74% 0.74%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Kyrgyzstan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
687 1,131 1,616 1,634 1,769 1,807
0.05 0.02 0.00 0.00 0.00 0.00 0.08
62.08 20.92 5.80 5.50 3.14 2.55 100.00
0.46 0.15 0.04 0.04 0.02 0.02 0.74
0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Bishkek Osh Dzhalal-Abad Przhevalsk Kyzyl-Kiya Naryn Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
213
9.12 LEBANON Biotechnology (US $ mln): Lebanon 1998 - 2008 Year
Lebanon
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.97% 0.99% 1.01% 1.04% 1.05% 1.04% 1.02% 1.00% 0.98% 0.96% 0.94%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Lebanon: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
518 986 1,388 1,603 1,955
0.08 0.03 0.01 0.01 0.00 0.12
64.82 21.61 8.64 4.32 0.61 100.00
0.67 0.22 0.09 0.04 0.01 1.04
0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Beirut Tripoli Zahle Sidon Tyre Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
214
9.13 OMAN Biotechnology (US $ mln): Oman 1998 - 2008 Year
Oman
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.13% 1.13% 1.13% 1.14% 1.14% 1.14% 1.13% 1.13% 1.13% 1.12% 1.12%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Oman: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
539 991 1,218 1,219
0.08 0.03 0.02 0.02 0.13
57.47 19.54 11.49 11.49 100.00
0.65 0.22 0.13 0.13 1.14
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Muscat Matrah Nizwa Salala Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
215
9.14 PAKISTAN Biotechnology (US $ mln): Pakistan 1998 - 2008 Year
Pakistan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
2 2 2 2 2 2 2 2 2 3 3
16.28% 16.31% 16.35% 16.38% 16.40% 16.38% 16.35% 16.32% 16.29% 16.25% 16.21%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Pakistan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
104 149 290 395 409 416 446 512 774 792 944
0.72 0.41 0.15 0.11 0.10 0.10 0.09 0.08 0.04 0.04 0.03 1.89
38.40 21.77 8.14 5.86 5.54 5.38 4.86 4.17 2.23 2.15 1.50 100.00
6.29 3.57 1.33 0.96 0.91 0.88 0.80 0.68 0.36 0.35 0.25 16.38
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Karachi Lahore Faisalabad Rawalpindi Hyderabad Multan Gujranwala Peshawar Sialkot Sargodha Islamabad Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
216
9.15 QATAR Biotechnology (US $ mln): Qatar 1998 - 2008 Year
Qatar
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.86% 0.86% 0.87% 0.87% 0.88% 0.87% 0.87% 0.86% 0.86% 0.85% 0.85%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Qatar: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
419
0.10 0.10
100.00 100.00
0.87 0.87
0.00 0.00
_________________________________________________________________________________________________________
Doha Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
9.16 SAUDI ARABIA Biotechnology (US $ mln): Saudi Arabia 1998 - 2008 Year
Saudi Arabia
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
1 1 1 1 1 2 2 2 2 2 2
13.17% 13.26% 13.34% 13.42% 13.48% 13.43% 13.35% 13.28% 13.20% 13.12% 13.04%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
217
Saudi Arabia: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
118 199 228 381 394 525 805 810 934 967 1,062 1,095 1,298 1,339
0.58 0.26 0.21 0.12 0.11 0.08 0.04 0.04 0.03 0.03 0.02 0.02 0.01 0.01 1.55
37.31 16.59 13.68 7.46 7.21 4.98 2.51 2.49 1.87 1.74 1.34 1.24 0.82 0.75 100.00
5.01 2.23 1.84 1.00 0.97 0.67 0.34 0.33 0.25 0.23 0.18 0.17 0.11 0.10 13.43
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Jiddah Riyadh Mecca Taif Medina Dammam Hufuf Haradh Tabuk Buraydah Al-Mubarraz Khamis-Mushait Jizan Abha Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
9.17 SYRIAN ARAB REPUBLIC Biotechnology (US $ mln): Syrian Arab Republic 1998 - 2008 Year
Syrian Arab Republic
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
2.86% 2.89% 2.91% 2.94% 2.96% 2.94% 2.92% 2.89% 2.87% 2.85% 2.82%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
218
Syrian Arab Republic: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
386 404 813 1,051 1,101 1,471 1,489 1,541 1,631 1,636 1,647
0.12 0.11 0.04 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.34
33.99 31.99 11.34 6.34 5.63 2.42 2.29 1.92 1.39 1.37 1.32 100.00
1.00 0.94 0.33 0.19 0.17 0.07 0.07 0.06 0.04 0.04 0.04 2.94
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Damascus Aleppo Homs Latakia Hama Dayr az-Zawr Raqqa Hasakeh Tartus Idlib Dar'a Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
9.18 TAJIKISTAN Biotechnology (US $ mln): Tajikistan 1998 - 2008 Year
Tajikistan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
219
Tajikistan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
895 1,465 1,735 1,752 1,871 1,906 1,951
0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.05
63.64 17.11 6.63 5.88 2.99 2.25 1.50 100.00
0.27 0.07 0.03 0.02 0.01 0.01 0.01 0.42
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Dushanbe Khodzhent Kulyab Kurgan-Tyube Kanibadam Tursunzade Khorog Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
9.19 TURKEY Biotechnology (US $ mln): Turkey 1998 - 2008 Year
Turkey
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
3 3 3 3 3 3 3 3 4 4 4
26.26% 26.16% 26.06% 25.95% 25.86% 25.94% 26.04% 26.14% 26.23% 26.32% 26.40%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
220
Turkey: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
73 165 168 258 277 316 323 363 554 575 631 643 646 720 786
1.15 0.36 0.34 0.18 0.16 0.14 0.14 0.12 0.07 0.07 0.06 0.06 0.06 0.05 0.04 2.99
38.42 12.01 11.51 5.94 5.30 4.65 4.54 4.07 2.42 2.28 1.99 1.97 1.95 1.57 1.37 100.00
9.97 3.11 2.99 1.54 1.38 1.21 1.18 1.05 0.63 0.59 0.52 0.51 0.51 0.41 0.36 25.94
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
_________________________________________________________________________________________________________
Istanbul Izmir Ankara Bursa Adana Mersin (Icel) Antalya Konya Samsun Gaziantep Kayseri Diyarbakir Eskisehir Sanli-Urfa Malatya Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
9.20 TURKMENISTAN Biotechnology (US $ mln): Turkmenistan 1998 - 2008 Year
Turkmenistan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
1.41% 1.34% 1.27% 1.20% 1.16% 1.20% 1.26% 1.32% 1.39% 1.46% 1.53%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
221
Turkmenistan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
533 904 1,053 1,381
0.08 0.03 0.02 0.01 0.14
54.82 22.18 15.43 7.58 100.00
0.66 0.27 0.19 0.09 1.20
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Ashgabat Chardzhou Tashauz Krasnovodsk Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
9.21 UNITED ARAB EMIRATES Biotechnology (US $ mln): United Arab Emirates 1998 - 2008 Year
United Arab Emirates
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 1
3.07% 3.09% 3.11% 3.12% 3.14% 3.12% 3.11% 3.09% 3.07% 3.05% 3.04%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
United Arab Emirates: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
349 373 624 661
0.13 0.12 0.06 0.06 0.36
35.47 32.40 16.67 15.47 100.00
1.11 1.01 0.52 0.48 3.12
0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Dubai Abu Dhabi Sharjah Ras al-Khaimah Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
222
9.22 UZBEKISTAN Biotechnology (US $ mln): Uzbekistan 1998 - 2008 Year
Uzbekistan
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 1 1
3.28% 3.33% 3.38% 3.44% 3.48% 3.44% 3.39% 3.34% 3.29% 3.25% 3.20%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Uzbekistan: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
271 746 1,014 1,029 1,133 1,195 1,243 1,277 1,311 1,312 1,393 1,404 1,410 1,440 1,459
0.16 0.04 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.40
41.18 11.24 6.12 5.82 4.45 3.97 3.62 3.36 3.10 3.10 2.60 2.54 2.48 2.26 2.13 2.03 100.00
1.42 0.39 0.21 0.20 0.15 0.14 0.12 0.12 0.11 0.11 0.09 0.09 0.09 0.08 0.07 0.07 3.44
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Tashkent Samarkand Namangan Andizhan Bukhara Fergana Kokand Nukus Chirchik Karshi Angren Urgench Margilan Almalyk Navoi Others Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
223
9.23 YEMEN Biotechnology (US $ mln): Yemen 1998 - 2008 Year
Yemen
% of Region
% of Globe
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
0 0 0 0 0 0 0 0 0 0 0
0.85% 0.85% 0.85% 0.84% 0.84% 0.84% 0.84% 0.85% 0.85% 0.85% 0.86%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
Yemen: Biotechnology in 2003, US $ mln City
World Rank
US $ mln
%Country
%Region
%World
878 1,016 1,271 1,333 1,334 1,795 1,965 1,975
0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.10
33.39 24.86 13.92 12.12 12.04 2.35 0.70 0.63 100.00
0.28 0.21 0.12 0.10 0.10 0.02 0.01 0.01 0.84
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
_________________________________________________________________________________________________________
Sanaa Aden Taizz Hodeida Mukalla Dhamar El Beida Hajja Total
_________________________________________________________________________________________________________
Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
224
10 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 10.1 DISCLAIMERS & SAFE HARBOR Summary disclaimer. This publication ("Report") does not constitute legal, valuation, tax, or financial consulting advice. Nor is it a statement on the performance, management capability or future potential (good or bad) of the company(ies), industry(ies), product(s), region(s), city(ies) or country(ies) discussed. It is offered as an information service to clients, associates, and academicians. Those interested in specific guidance for legal, strategic, and/or financial or accounting matters should seek competent professional assistance from their own advisors. Information was furnished to ICON Group Ltd. ("ICON Group"), and its subsidiaries (ICON Group International, Inc.), by its internal researchers and/or extracted from public filings, or sources available within the public domain, including other information providers (e.g. EDGAR filings, national organizations and international organizations). ICON Group does not promise or warrant that we will obtain information from any particular independent source. Published regularly by ICON Group, this and similar reports provide analysis on cities, countries, industries, and/or foreign and domestic companies which may or may not be publicly traded. ICON Group reports are used by various companies and persons including consulting firms, investment officers, pension fund managers, registered representatives, and other financial service professionals. Any commentary, observations or discussion by ICON Group about a country, city, region, industry or company does not constitute a recommendation to buy or sell company shares or make investment decisions. Further, the financial condition or outlook for each industry, city, country, or company may change after the date of the publication, and ICON Group does not warrant, promise or represent that it will provide report users with notice of that change, nor will ICON Group promise updates on the information presented. Safe Harbor for Forward-Looking Statements. ICON Group reports, including the present report, make numerous forward-looking statements which should be treated as such. Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995, and similar local laws. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's, city's, country's or industry's actual results or outlook in future periods to differ materially from those forecasted. These risks and uncertainties include, among other things, product price volatility, exchange rate volatility, regulation volatility, product demand volatility, data inaccuracies, computer- or softwaregenerated calculation inaccuracies, market competition, changes in management style, changes in corporate strategy, and risks inherent in international and corporate operations. Forward-looking statements can be identified in statements by the fact that they do not relate strictly to historical or
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
225
current facts. They use words such as "anticipate,'' "estimate," "expect,'' "project,'' "intend,'' "plan,'' "feel", "think", "hear," "guess," "forecast," "believe," and other words and terms of similar meaning in connection with any discussion of future operating, economic or financial performance. This equally applies to all statements relating to an industry, city, country, region, economic variable or company financial situation. ICON Group recommends that the reader follow the advice of Nancy M. Smith, Director of SEC's Office of Investor Education and Assistance, who has been quoted to say, "Never, ever, make an investment based solely on what you read in an online newsletter or Internet bulletin board, especially if the investment involves a small, thinly-traded company that isn't well known … Assume that the information about these companies is not trustworthy unless you can prove otherwise through your own independent research." Similar recommendations apply to decisions relating to industry studies, product category studies, corporate strategies discussions and country evaluations. In the case of ICON Group reports, many factors can affect the actual outcome of the period discussed, including exchange rate volatility, changes in accounting standards, the lack of oversight or comparability in accounting standards, changes in economic conditions, changes in competition, changes in the global economy, changes in source data quality, changes in reported data quality, changes in methodology and similar factors. Information Accuracy. Although the statements in this report are derived from or based upon various information sources and/or econometric models that ICON Group believes to be reliable, we do not guarantee their accuracy, reliability, quality, and any such information, or resulting analyses, may be incomplete, rounded, inaccurate or condensed. All estimates included in this report are subject to change without notice. This report is for informational purposes only and is not intended as a recommendation to invest in a city, country, industry or product area, or an offer or solicitation with respect to the purchase or sale of a security, stock, or financial instrument. This report does not take into account the investment objectives, financial situation or particular needs of any particular person or legal entity. With respect to any specific company, city, country, region, or industry that might be discussed in this report, investors should obtain individual financial advice based on their own particular circumstances before making an investment decision on the basis of the information in this report. Investing in either U.S. or nonU.S. securities or markets entails inherent risks. In addition, exchange rate movements may have an effect on the reliability of the estimates provided in this report. ICON Group is not a registered Investment Adviser or a Broker/Dealer.
10.2 ICON GROUP LTD. USER AGREEMENT PROVISIONS Ownership. User agrees that ICON Group Ltd. ("ICON Group") and its subsidiaries (ICON Group International, Inc.) retains all rights, title and interests, including copyright and other proprietary rights, in this report and all material, including but not limited to text, images, and other multimedia data, provided or made available as part of this report ("Report").
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
226
Restrictions on Use. User agrees that it will not copy nor license, sell, transfer, make available or otherwise distribute the Report to any entity or person, except that User may (a) make available to its employees electronic copies of Report, (b) allow its employees to store, manipulate, and reformat Report, and (c) allow its employees to make paper copies of Report, provided that such electronic and paper copies are used solely internally and are not distributed to any third parties. In all cases the User agrees to fully inform and distribute to other internal users all discussions covering the methodology of this Report and the disclaimers and caveats associated with this Report. User shall use its best efforts to stop any unauthorized copying or distribution immediately after such unauthorized use becomes known. The provisions of this paragraph are for the benefit of ICON Group and its information resellers, each of which shall have the right to enforce its rights hereunder directly and on its own behalf. No Warranty. The Report is provided on an "AS IS" basis. ICON GROUP DISCLAIMS ANY AND ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, RELATING TO THIS AGREEMENT, PERFORMANCE UNDER THIS AGREEMENT, THE REPORT. ICON Group makes no warranties regarding the completeness, accuracy or availability of the Report. Limitation of Liability. In no event shall ICON Group, its employees or its agent, resellers and distributors be liable to User or any other person or entity for any direct, indirect, special, exemplary, punitive, or consequential damages, including lost profits, based on breach of warranty, contract, negligence, strict liability or otherwise, arising from the use of the report or under this Agreement or any performance under this Agreement, whether or not they or it had any knowledge, actual or constructive, that such damages might be incurred. Indemnification. User shall indemnify and hold harmless ICON Group and its resellers, distributors and information providers against any claim, damages, loss, liability or expense arising out of User's use of the Report in any way contrary to this Agreement. © ICON Group Ltd., 2003. All rights reserved. Any unauthorized use, duplication or disclosure is prohibited by law and will result in prosecution. Text, graphics, and HTML or other computer code are protected by US and International Copyright Laws, and may not be copied, reprinted, published, translated, hosted, or otherwise distributed by any means without explicit permission. Permission is granted to quote small portions of this report with proper attribution. Media quotations with source attributions are encouraged. Reporters requesting additional information or editorial comments should contact ICON Group via email at [email protected]. Sources: This report was prepared from a variety of sources including excerpts from documents and official reports or databases published by the World Bank, the U.S. Department of Commerce, the U.S. State Department, various national agencies, the International Monetary Fund, the Central Intelligence Agency, the United Nations, and ICON Group Ltd.
www.icongrouponline.com
Ó2003 ICON Group Ltd.
Biotechnology
227
END
www.icongrouponline.com
Ó2003 ICON Group Ltd.